Exempt Chemical Preparations Under the Controlled Substances Act, 4446-4458 [2013-01133]
Download as PDF
4446
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–361]
Exempt Chemical Preparations Under
the Controlled Substances Act
Drug Enforcement
Administration (DEA), Department of
Justice.
ACTION: Order with opportunity for
comment.
AGENCY:
The applications for exempt
chemical preparations received by DEA
between June 12, 2011, and June 30,
2012, as listed below, were accepted for
filing and have been approved or denied
as indicated.
DATES: Electronic comments must be
submitted and written comments must
be postmarked on or before March 25,
2013. Commenters should be aware that
the electronic Federal Docket
Management System will not accept
comments after midnight Eastern Time
on the last day of the comment period.
ADDRESSES: To ensure proper handling
of comments, please reference ‘‘Docket
No. DEA–361’’ on all electronic and
written correspondence. DEA
encourages that all comments be
submitted electronically through https://
www.regulations.gov using the
electronic comment form provided on
that site. An electronic copy of this
document is also available at the https://
www.regulations.gov Web site for easy
reference. Paper comments that
duplicate the electronic submission are
not necessary as all comments
submitted to www.regulations.gov will
be posted for public review and are part
of the official docket record. Written
comments submitted via regular or
express mail should be sent to the Drug
Enforcement Administration, Attention:
DEA Federal Register Representative/
ODL, 8701 Morrissette Drive,
Springfield, Virginia 22152.
FOR FURTHER INFORMATION CONTACT: John
W. Partridge, Executive Assistant, Office
of Diversion Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152. Telephone: (202) 307–7165.
SUPPLEMENTARY INFORMATION:
SUMMARY:
tkelley on DSK3SPTVN1PROD with
Posting of Public Comments
Please note that all comments
received are considered part of the
public record and made available for
public inspection online at https://
www.regulations.gov and in the DEA’s
public docket. Such information
includes personal identifying
information (such as your name,
VerDate Mar<15>2010
18:11 Jan 18, 2013
Jkt 229001
address, etc.) voluntarily submitted by
the commenter.
If you want to submit personal
identifying information (such as your
name, address, etc.) as part of your
comment, but do not want it to be
posted online or made available in the
public docket, you must include the
phrase ‘‘PERSONAL IDENTIFYING
INFORMATION’’ in the first paragraph
of your comment. You must also place
all the personal identifying information
you do not want posted online or made
available in the public docket in the first
paragraph of your comment and identify
what information you want redacted.
If you want to submit confidential
business information as part of your
comment, but do not want it to be
posted online or made available in the
public docket, you must include the
phrase ‘‘CONFIDENTIAL BUSINESS
INFORMATION’’ in the first paragraph
of your comment. You must also
prominently identify confidential
business information to be redacted
within the comment. If a comment has
so much confidential business
information that it cannot be effectively
redacted, all or part of that comment
may not be posted online or made
available in the public docket.
Personal identifying information and
confidential business information
identified and located as set forth above
will be redacted, and the comment, in
redacted form, will be posted online and
placed in DEA’s public docket file.
Please note that the Freedom of
Information Act applies to all comments
received. If you wish to inspect the
agency’s public docket file in person by
appointment, please see the FOR
FURTHER INFORMATION CONTACT
paragraph.
SUPPLEMENTARY INFORMATION:
Legal Authority
DEA implements and enforces Titles
II and III of the Comprehensive Drug
Abuse Prevention and Control Act of
1970, often referred to as the Controlled
Substances Act and the Controlled
Substances Import and Export Act
(codified at Title 21, Chapter 13 of the
U.S.C.), as amended (hereinafter,
‘‘CSA’’). DEA drafts and publishes the
implementing regulations for these
statutes in Title 21 of the Code of
Federal Regulations (CFR), parts 1300 to
1321. The CSA and its implementing
regulations are designed to prevent,
detect, and eliminate the diversion of
controlled substances and listed
chemicals into the illicit market while
providing for a sufficient supply of
controlled substances and listed
chemicals for legitimate medical,
scientific, research, and industrial
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
purposes. Controlled substances have
the potential for abuse and dependence
and are controlled to protect the public
health and safety.
Section 201 of the CSA (21 U.S.C.
811) authorizes the Attorney General, by
regulation, to exempt from certain
provisions of the CSA certain
compounds, mixtures, or preparations
containing a controlled substance, if he
finds that such compounds, mixtures, or
preparations meet the requirements
detailed in 21 U.S.C. 811(g)(3)(B).1 DEA
regulations at 21 CFR 1308.23 and
1308.24 further detail the criteria by
which the DEA Deputy Assistant
Administrator may exempt a chemical
preparation or mixture from the
application of certain provisions of the
CSA. The Deputy Assistant
Administrator may, pursuant to 21 CFR
1308.23(f), modify or revoke the criteria
by which exemptions are granted and
modify the scope of exemptions at any
time.
Exempt Chemical Preparation
Applications Submitted Between June
12, 2011, and June 30, 2012
The Deputy Assistant Administrator
received applications between June 12,
2011, and June 30, 2012, requesting
exempt chemical preparation status
pursuant to 21 CFR 1308.23. Pursuant to
the criteria stated in 21 U.S.C.
811(g)(3)(B) and in 21 CFR 1308.23, the
Deputy Assistant Administrator has
found that each of the compounds,
mixtures, and preparations described in
Chart I below is intended for laboratory,
industrial, educational, or special
research purposes and not for general
administration to a human being or
other animal and either: (1) Contains no
narcotic controlled substance and is
packaged in such a form or
concentration that the packaged
quantity does not present any
significant potential for abuse; or (2)
contains either a narcotic or nonnarcotic controlled substance and one or
more adulterating or denaturing agents
in such a manner, combination,
quantity, proportion, or concentration
that the preparation or mixture does not
present any potential for abuse; if the
preparation or mixture contains a
narcotic controlled substance, it must be
formulated in such a manner that it
incorporates methods of denaturing or
other means so that the preparation or
mixture is not liable to be abused or
have ill effects if abused, and so that the
1 This authority has been delegated from the
Attorney General to the Administrator of the DEA
by 28 CFR 0.100 and subsequently redelegated to
the Deputy Assistant Administrator pursuant to the
Appendix to Subpart R of 28 CFR 0.104.
E:\FR\FM\22JAN1.SGM
22JAN1
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
narcotic substance cannot in practice be
removed.
Accordingly, pursuant to 21 U.S.C.
811(g)(3)(B), 21 CFR 1308.23, and 21
CFR 1308.24, the Deputy Assistant
Administrator has determined that each
of the chemical preparations or mixtures
generally described in Chart I below and
specifically described in the application
materials received by DEA, are exempt
from application of sections 302, 303,
305, 306, 307, 308, 309, 1002, 1003, and
1004 (21 U.S.C. 822–823, 825–829, and
4447
952–954) of the CSA and from
application of 21 CFR 1301.74, to the
extent described in 21 CFR 1308.24, as
of the date listed below that was
provided in the approval letters to the
individual requesters.
CHART I
Supplier
Product name
Form
Exemption
date
Abbott Laboratories ............................
ARCHITECT 2nd Generation Testosterone Calibrators (B,C,D,E,F).
ARCHITECT 2nd Generation Testosterone Controls (L,M,H).
ARCHITECT Estradiol Assay Diluent, No. 2K25J
Bottle: 4 mL; Box: 6 bottles ...............
12/22/2011
Bottle: 8 mL; Box: 3 bottles ...............
12/22/2011
Bag-in-box: 18–200 L; Flask/Carboy:
1–50 L; Bottle/Vial: 0.5 mL–1 L;
Box: 1–50 bottles.
Bottle: 5.9 mL .....................................
Bottle: 5.9 mL; Kit: 16 bottles ............
12/22/2011
12/22/2011
12/22/2011
Bottle: 5.9 mL; Kit: 4 bottles ..............
12/22/2011
Bottle: 5.9 mL; Kit: 16 bottles ............
Bottle: 5.9 mL; Kit: 4 bottles ..............
Flask/Carboy: 1–50 L; Bottle/Vial: 0.5
mL–1 L; Box: 1–50 bottles.
Bottle: 5.5 mL, Pack: 4 bottles ..........
Plastic Vial: 50 discs ..........................
12/22/2011
12/22/2011
12/22/2011
Plastic Vial: 50 discs ..........................
12/22/2011
Plastic Vial: 50 discs ..........................
12/22/2011
Plastic Vial: 50 discs ..........................
12/22/2011
Plastic Vial: 50 discs ..........................
12/22/2011
Plastic Vial: 50 discs ..........................
12/22/2011
Plastic Vial: 50 discs ..........................
12/22/2011
Plastic Vial: 50 discs ..........................
12/22/2011
Glass jar: 100 Chromatograms ..........
Glass jar: 100 Chromatograms ..........
Plastic vial: 50 discs ..........................
Plastic bottle: 2 oz .............................
Plastic bottle: 2 oz. ............................
Plastic bottle: 2 oz .............................
Plastic bottle: 2 oz .............................
Plastic vial: 50 discs ..........................
Plastic vial: 50 discs ..........................
Plastic vial: 50 discs ..........................
Plastic vial: 50 discs ..........................
Plastic vial: 50 discs ..........................
Plastic vial: 50 discs ..........................
Plastic vial: 50 discs ..........................
Plastic vial: 50 discs ..........................
Plastic vial: 50 discs ..........................
Plastic vial: 50 discs ..........................
Plastic vial: 50 discs ..........................
Plastic vial: 50 discs ..........................
Plastic vial: 50 discs ..........................
Plastic bottle: 2 oz .............................
Vial: 1 mL ...........................................
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
(+)-Pentazocine (1 mg/mL) ....................................
Vial: 1 mL ...........................................
12/22/2011
(+)-Pentazocine [ring-1,3-3H] .................................
Vial: 1 mL ...........................................
12/22/2011
(±)-Ketamine [N-methyl-3H] hydrochloride .............
Vial: 1 mL ...........................................
12/22/2011
Abbott Laboratories ............................
Abbott Laboratories ............................
Abbott Laboratories ............................
Abbott Laboratories ............................
Abbott Laboratories ............................
Abbott Laboratories ............................
Abbott Laboratories ............................
Abbott Laboratories ............................
Abbott Laboratories ............................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
tkelley on DSK3SPTVN1PROD with
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
Agilent Technologies ..........................
American Radiolabeled Chemicals,
Inc.
American Radiolabeled Chemicals,
Inc.
American Radiolabeled Chemicals,
Inc.
American Radiolabeled Chemicals,
Inc.
VerDate Mar<15>2010
18:11 Jan 18, 2013
ARCHITECT Estradiol Assay Diluent, No. 7K72J
ARCHITECT Estradiol Reagent Kit, No. 07K72–
20.
ARCHITECT Estradiol Reagent Kit, No. 07K72–
25.
ARCHITECT Estradiol Reagent Kit, No. 2K25–20
ARCHITECT Estradiol Reagent Kit, No. 2K25–25
AxSYM Estradiol Buffer .........................................
AxSYM Estradiol Reagent Pack ............................
Special Order Standard TOXI-LAB DISCS; 1, 2,
or 3 drugs.
Special Procedure Standard TOXI-LAB DISCS:
Benzodiazepines: Hydrolysis Procedure.
Special Procedure Standard TOXI-LAB DISCS:
Benzoylecgonine.
Special Procedure Standard TOXI-LAB DISCS:
MDMA, MDA, MDEA.
Special Procedure Standard TOXI-LAB DISCS:
Morphine and Hydromorphone: Differentiation.
Special Procedure Standard TOXI-LAB DISCS:
Opiate.
Special Procedure Standard TOXI-LAB DISCS:
Sympathomimetic amines: Differentiation.
Special Standard TOXI-LAB DISCS LTD-Opiate:
1, 2, or 3 drugs.
TOXI-LAB Chromatograms A ................................
TOXI-LAB Chromatograms B ................................
TOXI-LAB CONTROL LTD FM ..............................
TOXI-LAB CONTROL No. 19 ................................
TOXI-LAB CONTROL No. 2 ..................................
TOXI-LAB CONTROL No. 3 ..................................
TOXI-LAB CONTROL No. 5 ..................................
TOXI-LAB CONTROL THC ....................................
TOXI-LAB DISCS A–1 ...........................................
TOXI-LAB DISCS A–2 ...........................................
TOXI-LAB DISCS A–3 ...........................................
TOXI-LAB DISCS A–4 ...........................................
TOXI-LAB DISCS B–1 ...........................................
TOXI-LAB DISCS B–2 ...........................................
TOXI-LAB DISCS B–3 ...........................................
TOXI-LAB DISCS B–4 ...........................................
TOXI-LAB DISCS LTD HD ....................................
TOXI-LAB DISCS LTD OP ....................................
TOXI-LAB DISCS LTD OPI ...................................
TOXI-LAB DISCS THC ..........................................
TOXI-LAB Proficiency Sample ...............................
(+)-iodo-Lysergic Acid diethylamide [125I] .............
Jkt 229001
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
E:\FR\FM\22JAN1.SGM
22JAN1
12/22/2011
12/22/2011
4448
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
CHART I—Continued
Product name
Form
Exemption
date
Radiolabeled Chemicals,
(±)-Ketamine hydrochloride (1 mg/mL) ..................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
1,1-Dimethyltryptamine (1 mg/mL) .........................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
1,1-Dimethyltryptamine [a,b-3H] as TFA salt .........
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Amobarbital (1 mg/mL) ..........................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Amphetamine, D-[ring-2,3,5-3H] hydrochloride .....
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Amphetamine, DL-[ring-2,3,5-3H] hydrochloride ...
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Amphetamine, L-[ring-2,3,5-3H] hydrochloride ......
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Buprenorphine [ring-3H] hydrochloride ..................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Buprenorphine hydrochloride (1 mg/mL) ...............
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Cocaine (1 mg/mL) ................................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Cocaine [methyl-14C] hydrochloride ......................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Cocaine, levo-[benzoyl-3,4-3H(N)] .........................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Codeine (1 mg/mL) ................................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
D-Amphetamine hydrochloride (1 mg/mL) .............
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Dextropropoxyphene (1 mg/mL) ............................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Diazepam (1 mg/mL) .............................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Dihydrocodeine (1 mg/mL) .....................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Dihydromorphine (1 mg/mL) ..................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Diprenorphine (1 mg/mL) .......................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
DL-Amphetamine hydrochloride (1 mg/mL) ...........
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
D-Methamphetamine hydrochloride (1 mg/mL) .....
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Ecgonine (1 mg/mL) ...............................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Fentanyl (1 mg/mL) ................................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Fentanyl [3H(G)] as TFA salt .................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Fludiazepam (1 mg/mL) .........................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Flunitrazepam (1 mg/mL) .......................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Flunitrazepam [methyl-3H] .....................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Flurazepam (1 mg/mL) ...........................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Flurazepam [N-methyl-3H] .....................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Heroin (1 mg/mL) ...................................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Heroin [methyl-14C] ...............................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Heroin [methyl-3H] .................................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Hydrocodone (1 mg/mL) ........................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Hydromorphone (1 mg/mL) ....................................
Vial: 1 mL ...........................................
12/22/2011
Radiolabeled Chemicals,
Hydromorphone [N-methyl-14C] hydrochloride .....
Vial: 1 mL ...........................................
12/22/2011
tkelley on DSK3SPTVN1PROD with
Supplier
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
American
Inc.
VerDate Mar<15>2010
18:11 Jan 18, 2013
Jkt 229001
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
E:\FR\FM\22JAN1.SGM
22JAN1
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
4449
CHART I—Continued
Product name
Form
Exemption
date
Chemicals,
Ibogaine (1 mg/mL) ................................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
L-Amphetamine hydrochloride (1 mg/mL) .............
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
L-Methamphetamine hydrochloride (1 mg/mL) ......
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Lysergic Acid (1 mg/mL) ........................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Lysergic acid diethylamide [N-methyl-3H] .............
Vial: 1 mL ...........................................
3/22/2012
Chemicals,
Mazindol (1 mg/mL) ...............................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Meperidine Hydrochloride (1 mg/mL) ....................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Metazocine (1 mg/mL) ...........................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Metazocine [ring-1,3-3H] ........................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Methamphetamine, D-[methyl-14C] hydrochloride
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Methamphetamine, L-[methyl-14C] hydrochloride
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Midazolam (1 mg/mL) ............................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Midazolam [3H(G)] .................................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Morphine (1 mg/mL) ...............................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Morphine [N-methyl-14C] .......................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Normorphine (1 mg/mL) .........................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Oripavine (1 mg/mL) ..............................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Oxycodone [N-methyl-14C] hydrochloride .............
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Oxycodone hydrochloride (1 mg/mL) .....................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Oxymorphone (1 mg/mL) .......................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Phenazocine (1 mg/mL) .........................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Phencyclidine hydrochloride (1 mg/mL) .................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Phenylacetone (1 mg/mL) ......................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Tetrahydrocannabidinol (1 mg/mL) ........................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Thebaine (1 mg/mL) ...............................................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Thebaine [N-methyl-14C] hydrochloride ................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Thebaine [N-methyl-3H] hydrochloride ..................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Thebaine [O-methyl-14C] hydrochloride ................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
Thebaine [O-methyl-3H] hydrochloride ..................
Vial: 1 mL ...........................................
12/22/2011
Chemicals,
g-Hydroxybutyric acid sodium salt (1 mg/mL) ........
Vial: 1 mL ...........................................
12/22/2011
Detectabuse
OF10.
Detectabuse
OF11.
Detectabuse
OF12.
Detectabuse
OF13.
Detectabuse
OF14.
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Supplier
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
American Radiolabeled
Inc.
Biochemical Diagnostics,
Inc .............
tkelley on DSK3SPTVN1PROD with
Biochemical Diagnostics, Inc .............
Biochemical Diagnostics, Inc .............
Biochemical Diagnostics, Inc .............
Biochemical Diagnostics, Inc .............
VerDate Mar<15>2010
18:11 Jan 18, 2013
Jkt 229001
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
E:\FR\FM\22JAN1.SGM
22JAN1
4450
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
CHART I—Continued
Supplier
Product name
Biochemical Diagnostics, Inc .............
Biochemical Diagnostics, Inc .............
Biochemical Diagnostics, Inc .............
Biochemical Diagnostics, Inc .............
Biochemical Diagnostics, Inc .............
Biochemical Diagnostics, Inc .............
Biochemical Diagnostics, Inc .............
Biochemical Diagnostics, Inc .............
Biochemical Diagnostics, Inc .............
Biochemical Diagnostics, Inc .............
Biochemical Diagnostics, Inc .............
tkelley on DSK3SPTVN1PROD with
Biochemical Diagnostics, Inc .............
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Biochemical
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
Diagnostics,
VerDate Mar<15>2010
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Inc
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
18:11 Jan 18, 2013
Detectabuse
OF15.
Detectabuse
OF16.
Detectabuse
OF17.
Detectabuse
OF18.
Detectabuse
OF19.
Detectabuse
OF20.
Detectabuse
OF21.
Detectabuse
OF4.
Detectabuse
OF5.
Detectabuse
OF6.
Detectabuse
OF8.
Detectabuse
OF9.
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Detectabuse
Jkt 229001
PO 00000
Exemption
date
Form
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/31/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/31/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom Liquid Control Oral Fluid,
Glass vials: 1 ml–200 mL ..................
7/5/2012
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Custom
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Frm 00074
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Fmt 4703
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Urine,
Sfmt 4703
MC134
MC135
MC136
MC137
MC138
MC139
MC140
MC141
MC143
MC144
MC145
MC146
MC147
MC148
MC149
MC150
MC151
MC152
MC153
MC154
MC155
MC156
MC157
MC158
MC159
MC160
MC161
MC162
MC163
MC164
MC165
MC166
MC167
MC168
MC169
MC170
MC171
MC172
MC173
SD10
SD11
SD12
SD13
SD14
SD15
SD16
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
vials:
E:\FR\FM\22JAN1.SGM
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
ml–200
ml–200
ml–100
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
ml–200
22JAN1
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
2/1/2012
3/8/2012
3/8/2012
3/8/2012
3/8/2012
3/8/2012
3/22/2012
7/5/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
8/20/2012
7/5/2012
7/31/2012
7/31/2012
2/1/2012
2/1/2012
2/1/2012
2/1/2012
2/1/2012
7/5/2012
7/5/2012
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
4451
CHART I—Continued
Supplier
Product name
Form
Exemption
date
Bio-Rad Laboratories .........................
Liquichek Immunoassay Plus Control Levels 1, 2,
and 3.
Liquichek Immunoassay Plus Control Trilevel .......
Liquichek Immunoassay Plus Control Trilevel
Minipak.
Liquichek Urine Toxicology Control S10 ................
Liquichek Urine Toxicology Control S10 Low Opiate.
Liquichek Urine Toxicology Control S10 Low Opiate Minipak.
Liquichek Urine Toxicology Control S10 Minipak ..
Liquichek Urine Toxicology Control S20 ................
Liquichek Urine Toxicology Control S20 Low Opiate.
Liquichek Urine Toxicology Control S20 Low Opiate Minipak.
Liquichek Urine Toxicology Control S20 Minipak ..
Liquid Assayed Multiqual Levels 1–3 ....................
Liquid Assayed Multiqual Trilevel MiniPak ............
Liquid Unassayed Multiqual Levels 1–3 ................
Liquid Unassayed Multiqual Trilevel MiniPak ........
Lyphochek Assayed Chemistry Control Bilevel
MiniPak.
Lyphochek Assayed Chemistry Control Levels 1–
2.
Lyphochek Immunoassay Plus Control Levels 1,
2, and 3.
Lyphochek Immunoassay Plus Control Trilevel .....
Lyphochek Immunoassay Plus Control Trilevel
Minipak.
Lyphochek
Unassayed
Chemistry
Control
(Human) Bilevel MiniPak.
Lyphochek
Unassayed
Chemistry
Control
(Human) Levels 1–2.
(±) Pentazocine-13C3 (0.1 mg/mL) ........................
(±)-cis-11-Nor-9-carboxy-delta9-THC-D3
glucuronide (0.1 mg/mL).
3,4-Methylenedioxypyrovalerone HCl (1 mg/mL) ..
3,4-Methylenedioxypyrovalerone-D8 HCl (0.1 mg/
mL).
3-Desmethylprodine (1 mg/mL) .............................
3-Desmethylprodine HCl (1 mg/mL) ......................
6-alpha/beta-Hydroxyoxymorphone (1 mg/mL) .....
6-alpha/beta-Hydroxyoxymorphone-D3 (0.1 mg/
mL).
Buprenorphine N-oxide (1 mg/mL) ........................
Cannabinol-D3 (0.1 mg/mL) ...................................
Carisoprodol (1 mg/mL) .........................................
Carisoprodol-D7 (0.1 mg/mL) ................................
Carisoprodol-D7 (1 mg/mL) ...................................
Cocaine N-oxide HCl (1 mg/mL) ............................
Cocaine N-oxide HCl (1 mg/mL) ............................
Cocaine N-oxide-D3 HCl (0.1 mg/mL) ...................
Cocaine N-oxide-D3 HCl (0.1 mg/mL) ...................
Drug Solution # 15 .................................................
Lacosamide (1 mg/mL) ..........................................
Lacosamide-13C, D3 (0.1 mg/mL) .........................
Lacosamide-13C, D3 (1 mg/mL) ............................
Lisdexamfetamine dimesylate (1 mg/mL) ..............
Lisdexamfetamine-D4 dimesylate (0.1 mg/mL) .....
Mephedrone HCl (1 mg/mL) ..................................
Mephedrone-D3 HCl (0.1 mg/mL) .........................
Methylone HCl (1 mg/mL) ......................................
Methylone-D3 HCl (0.1 mg/mL) .............................
Morphine (8 μg/mL) ................................................
Naloxone N-oxide (0.1 mg/mL) ..............................
Norcodeine-D3 (1 mg/mL) .....................................
Normeperidine-D4 (1 mg/mL) ................................
Noroxycodone and Norhydrocodone Mix (0.5 mg/
mL).
Opiate Internal Standard Mix-15 ............................
Amber Vial: 10 mL; Box: 12 vials ......
12/22/2011
Amber Vial: 10 mL; Box: 12 vials ......
Amber Vial: 5 mL; Box: 3 vials ..........
12/22/2011
12/22/2011
Box: 10 vials, 10 mL each .................
Box: 10 vials, 10 mL each .................
5/31/2012
5/31/2012
Amber vial: 10 mL ..............................
5/31/2012
Amber vial: 10 mL ..............................
Box: 10 vials, 10 mL each .................
Box: 10 vials, 10 mL each .................
5/31/2012
5/31/2012
5/31/2012
Amber vial: 10 mL ..............................
5/31/2012
Amber vial: 10 mL ..............................
Amber Vial: 2.5 mL; Box: 12 vials .....
Amber Vial: 2.5 mL; Box: 3 vials .......
Amber Vial: 2.5 mL; Box: 12 vials .....
Amber Vial: 2.5 mL; Box: 3 vials .......
Box 2 vials; 5 mL each ......................
5/31/2012
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
Amber Vial: 5 mL; Box: 12 vials ........
12/22/2011
Amber Vial: 10 mL; Box: 12 vials ......
12/22/2011
Amber Vial: 10 mL; Box: 12 vials ......
Amber Vial: 5 mL; Box: 3 vials ..........
12/22/2011
12/22/2011
Box 2 vials; 5 mL each ......................
12/22/2011
Amber Vial: 5 mL; Box: 25 vials ........
12/22/2011
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
12/22/2011
12/22/2011
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
12/22/2011
12/22/2011
Glass
Glass
Glass
Glass
..........................
..........................
..........................
..........................
7/31/2012
7/31/2012
12/22/2011
12/22/2011
Glass Ampule: 1 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Screw-cap Vial: 50 mL .......................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 1 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 2 mL ..........................
Glass Ampule: 1 mL ..........................
Glass Ampule: 1 mL ..........................
Glass Ampule: 2 mL ..........................
12/22/2011
12/22/2011
12/22/2012
12/22/2012
7/31/2012
12/22/2011
3/8/2012
12/22/2011
3/8/2012
6/5/2012
5/31/2012
12/22/2011
7/31/2012
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
6/5/2012
7/31/2012
7/31/2012
12/22/2011
Glass Ampule: 2 mL ..........................
12/22/2011
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad
Bio-Rad
Bio-Rad
Bio-Rad
Bio-Rad
Bio-Rad
Laboratories
Laboratories
Laboratories
Laboratories
Laboratories
Laboratories
.........................
.........................
.........................
.........................
.........................
.........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
tkelley on DSK3SPTVN1PROD with
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Corporation
Corporation
Corporation
Corporation
.........................
.........................
.........................
.........................
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
.........................
Cerilliant Corporation .........................
VerDate Mar<15>2010
18:11 Jan 18, 2013
Jkt 229001
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Ampule:
Ampule:
Ampule:
Ampule:
E:\FR\FM\22JAN1.SGM
1
1
2
2
mL
mL
mL
mL
22JAN1
4452
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
CHART I—Continued
Supplier
Cerilliant Corporation
Cerilliant Corporation
Cerilliant Corporation
Cerilliant Corporation
ElSohly Laboratories,
Product name
.........................
.........................
.........................
.........................
Inc ...................
ElSohly Laboratories, Inc ...................
Environmental Resource Associates
(ERA).
Environmental Resource Associates
(ERA).
Environmental Resource Associates
(ERA).
Immunalysis Corporation ...................
Immunalysis Corporation ...................
Immunalysis Corporation ...................
Immunalysis Corporation ...................
Immunalysis Corporation ...................
Immunalysis Corporation ...................
Immunalysis Corporation ...................
Immunalysis Corporation ...................
Immunalysis Corporation ...................
Insys Therapeutics, Inc. .....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
tkelley on DSK3SPTVN1PROD with
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
VerDate Mar<15>2010
18:11 Jan 18, 2013
Form
Pseudobuprenorphine dihydrochloride (1.0mg/mL)
Pyrovalerone HCl (1 mg/mL) .................................
Secobarbital-D5 (1 mg/mL) ....................................
Zolpidem-D7 (0.1 mg/mL) ......................................
ELI Drug Standards D9-Tetrahydrocannabinolglucoronide (10 μg/mL in MeOH).
ELI Drug Standards D9-Tetrahydrocannabinolglucoronide (100 μg/mL in MeOH).
Chloral Hydrate, Proficiency Testing Material,
Catalog No. 853.
Chloral Hydrate, Reference Material, Catalog No.
676.
Waters Steroid Test Mix, Part No. 07364 ..............
Glass
Glass
Glass
Glass
Glass
Methadone Calibrator Levels 1–4 ..........................
Methadone High Control ........................................
Methadone Low Control .........................................
Oral Fluid Cutoff Calibrator Pain Management
Prediluted in Extraction Buffer.
Oral Fluid High Positive Control Pain Management Prediluted in Extration Buffer.
Oral Fluid Low Positive Control Pain Management
Prediluted in Extraction Buffer.
Zolpidem Calibrator ................................................
Zolpidem High Control ...........................................
Zolpidem Low Control ............................................
(-)-delta9-Tetrahydrocannabinol (1.0 mg/mL) ........
CEDIA Amphetamine OFT Assay, Catalog Number: 10014947.
CEDIA Cannabinoids OFT Assay, Catalog Number: 10014910.
CEDIA Cocaine OFT Assay, Catalog Number:
10014764.
CEDIA Methamphetamine OFT Assay, Catalog
Number: 10014949.
CEDIA Methamphetamine OFT Control Set (Low
and High) , Catalog #10014953.
CEDIA Methamphetamine OFT Cutoff Calibrator,
Catalog #10014951.
CEDIA Methamphetamine OFT High Calibrator,
Catalog #10014952.
CEDIA Multi-Drug OFT Control Set (Low and
High), Catalog #10014957.
CEDIA Multi-Drug OFT Cutoff Calibrator, Catalog
#10014955.
CEDIA Multi-Drug OFT High Calibrator, Catalog
#10014956.
CEDIA Opiate OFT Assay, Catalog Number:
10014873.
CEDIA PCP OFT Assay, Catalog Number:
10014888.
CEDIA THC OFT Control Set (Low and High),
Catalog #10014925.
CEDIA THC OFT Cutoff Calibrator, Catalog
#10014923.
CEDIA THC OFT High Calibrator, Catalog
#10014924.
Thermo Scientific CEDIA Methamphetamine OFT
Calibrator 1, Catalog Number: 10016345.
Thermo Scientific CEDIA Methamphetamine OFT
Calibrator 1, Catalog Number: 10016362.
Thermo Scientific CEDIA Methamphetamine OFT
Calibrator 2, Catalog Number: 10016346.
Thermo Scientific CEDIA Methamphetamine OFT
Calibrator 2, Catalog Number: 10016363.
Thermo Scientific CEDIA Methamphetamine OFT
Calibrator 3, Catalog Number: 10016347.
Thermo Scientific CEDIA Methamphetamine OFT
Calibrator 3, Catalog Number: 10016364.
Thermo Scientific CEDIA Methamphetamine OFT
Calibrator 4, Catalog Number: 10016348.
Glass
Glass
Glass
Glass
Jkt 229001
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Exemption
date
Ampule: 1 mL ..........................
Ampule: 2 mL ..........................
Ampule: 1 mL ..........................
Ampule: 2 mL ..........................
vial: 1 ml ..................................
2/1/2012
12/22/2011
7/31/2012
12/22/2011
5/31/2012
Glass vial: 1 ml ..................................
5/31/2012
Glass Ampule: 2 mL ..........................
3/8/2012
Glass Ampule: 2 mL ..........................
3/8/2012
Glass Ampule: 2 mL ..........................
3/8/2012
vial:
vial:
vial:
vial:
...............................
...............................
...............................
...............................
6/19/2012
6/19/2012
6/19/2012
6/19/2012
Glass vial: 10 mL ...............................
6/19/2012
Glass vial: 10 mL ...............................
6/19/2012
Glass vial: 10 mL ...............................
Glass vial: 10 mL ...............................
Glass vial: 10 mL ...............................
Glass Ampule: 1 mL ..........................
Box: 4 bottles; 65 mL each ................
6/19/2012
6/19/2012
6/19/2012
5/9/2012
12/22/2011
Box: 4 bottles; 65 mL each ................
12/22/2011
Box: 4 bottles; 65 mL each ................
12/22/2011
Box: 4 bottles; 65 mL each ................
12/22/2011
Vial: 10 mL Box: 2 vials .....................
12/22/2011
Vial: 5 mL Box: 1 vial .........................
12/22/2011
Vial: 5 mL Box: 1 vial .........................
12/22/2011
Vial: 15 mL Box: 2 vials .....................
12/22/2011
Vial: 10 mL Box: 1 vial .......................
12/22/2011
Vial: 10 mL Box: 1 vial .......................
12/22/2011
Box: 4 bottles; 65 mL each ................
12/22/2011
Box: 4 bottles; 65 mL each ................
12/22/2011
Vial: 10 mL Box: 2 vials .....................
12/22/2011
Vial: 5 mL Box: 1 vial .........................
12/22/2011
Vial: 5 mL Box: 1 vial .........................
12/22/2011
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
E:\FR\FM\22JAN1.SGM
10
10
10
10
mL
mL
mL
mL
22JAN1
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
4453
CHART I—Continued
Exemption
date
Supplier
Product name
Form
Microgenics Corporation ....................
Thermo Scientific CEDIA Methamphetamine OFT
Control Set (Low and High), Catalog Number:
10016349.
Thermo Scientific CEDIA Methamphetamine OFT
Control Set (Low and High), Catalog Number:
10016365.
Thermo Scientific CEDIA Methamphetamine OFT
Control Set (Low and High), Catalog Number:
10016808.
Thermo Scientific CEDIA Methamphetamine OFT
Cutoff Calibrator, Catalog Number: 10016807.
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 1, Catalog Number: 10016865.
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 1, Catalog Number: 10016882.
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 2, Catalog Number: 10016866.
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 2, Catalog Number: 10016883.
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 3, Catalog Number: 10016867.
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 3, Catalog Number: 10016884.
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 4, Catalog Number: 10016868.
Thermo Scientific CEDIA Multi-Drug OFT Control
Set (Low and High), Catalog Number:
10016869.
Thermo Scientific CEDIA Multi-Drug OFT Control
Set (Low and High), Catalog Number:
10016885.
Thermo Scientific CEDIA Multi-Drug OFT Control
Set (Low and High), Catalog Number:
10016895.
Thermo Scientific CEDIA Multi-Drug OFT Cutoff
Calibrator, Catalog Number: 10016894.
Thermo Scientific CEDIA THC OFT Calibrator 1
Catalog Number: 10016644.
Thermo Scientific CEDIA THC OFT Calibrator 1
Catalog Number: 10016700.
Thermo Scientific CEDIA THC OFT Calibrator 2
Catalog Number: 10016646.
Thermo Scientific CEDIA THC OFT Calibrator 2
Catalog Number: 10016701.
Thermo Scientific CEDIA THC OFT Calibrator 3
Catalog Number: 10016647.
Thermo Scientific CEDIA THC OFT Calibrator 3
Catalog Number: 10016702.
Thermo Scientific CEDIA THC OFT Calibrator 4
Catalog Number: 10016648.
Thermo Scientific CEDIA THC OFT Control Set
(Low and High), Catalog Number: 10016649.
Thermo Scientific CEDIA THC OFT Control Set
(Low and High), Catalog Number: 10016703.
Thermo Scientific CEDIA THC OFT Control Set
(Low and High), Catalog Number: 10016731.
Thermo Scientific CEDIA THC OFT Cutoff Calibrator Catalog Number: 10016730.
Thermo Scientific DRI Fentanyl Assay Catalog
Number: 10016005.
Thermo Scientific DRI Fentanyl Assay Catalog
Number: 10016006.
Thermo Scientific DRI Fentanyl Assay Catalog
Number: 10016437.
Thermo Scientific DRI Fentanyl Calibrator 2 ng/
mL Catalog Number: 10016023.
Thermo Scientific DRI Fentanyl High Control 1 ng/
mL Catalog Number: 10016484.
Thermo Scientific DRI Fentanyl High Control 2 ng/
mL Catalog Number: 10016485.
Vial: 10 mL Box: 2 vials .....................
7/5/2012
Vial: 10 mL Box: 2 vials .....................
7/5/2012
Vial: 10 mL Box: 2 vials .....................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 10 mL Box: 1 vial .......................
7/5/2012
Vial: 10 mL Box: 1 vial .......................
7/5/2012
Vial: 10 mL Box: 1 vial .......................
7/5/2012
Vial: 10 mL Box: 1 vial .......................
7/5/2012
Vial: 10 mL Box: 1 vial .......................
7/5/2012
Vial: 10 mL Box: 1 vial .......................
7/5/2012
Vial: 10 mL Box: 1 vial .......................
7/5/2012
Vial: 15 mL Box: 2 vials .....................
7/5/2012
Vial: 15 mL Box: 2 vials .....................
7/5/2012
Vial: 15 mL Box: 2 vials .....................
7/5/2012
Vial: 10 mL Box: 1 vial .......................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vial: 10 mL Box: 2 vials .....................
7/5/2012
Vial: 10 mL Box: 2 vials .....................
7/5/2012
Vial: 10 mL Box: 2 vials .....................
7/5/2012
Vial: 5 mL Box: 1 vial .........................
7/5/2012
Vials: 500 mL .....................................
5/31/2012
3 vials, 18 mL each ...........................
5/31/2012
3 vials, 18 mL each ...........................
5/31/2012
Vials: 10 mL .......................................
5/31/2012
Box: 1 vial; 25 mL ..............................
5/31/2012
Box: 1 vial; 10 mL ..............................
5/31/2012
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
tkelley on DSK3SPTVN1PROD with
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
VerDate Mar<15>2010
18:11 Jan 18, 2013
Jkt 229001
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
E:\FR\FM\22JAN1.SGM
22JAN1
4454
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
CHART I—Continued
Exemption
date
Supplier
Product name
Form
Microgenics Corporation ....................
Thermo Scientific DRI Fentanyl High Control 3 ng/
mL Catalog Number: 10016024.
Thermo Scientific DRI Fentanyl High Control 3 ng/
mL Catalog Number: 10016486.
Thermo Scientific DRI Fentanyl Low Control 1 ng/
mL Catalog Number: 10016022.
Thermo Scientific MAS Omni•CORE Liquid Assayed Integrated Chemistry Control Levels 1–3.
Thermo Scientific MAS Omni•CORE Liquid Assayed Integrated Chemistry Control Sample
Pack.
Thermo Scientific MAS Omni•IMMUNE Liquid Assayed Integrated Chemistry Control Levels 1–3.
Thermo Scientific MAS Omni•IMMUNE Liquid Assayed Integrated Chemistry Control Sample
Pack.
Thermo Scientific MAS Omni•IMMUNE PRO Liquid Assayed Integrated Chemistry Control Levels 1–3.
Thermo Scientific MAS Omni•IMMUNE PRO Liquid Assayed Integrated Chemistry Control Sample Pack.
Appendix IX Mix #1, Revised .................................
Custom a,a-Dimethylphenethylamine Standard ....
Custom Chloral Hydrate Standard .........................
Custom LS4434 Standard 1 ..................................
Metabolomic Standard Mix #1 ...............................
UCMR3 Method 539 Calibration Standard ............
UCMR3 Method Calibration Standard ...................
Oral Fluid DAT Cal A Levels 1–5 ..........................
Oral Fluid DAT Cal B Levels 1–5 ..........................
Oral Fluid DAT Control Set A Material No.
05473390190.
Oral Fluid DAT Control Set B Material No.
05473411190.
Oral Fluid DAT Qual Cal Material No.
05475929190.
Oral Fluid DAT SQ Cal A Material No.
05475872190.
Oral Fluid DAT SQ Cal B Material No.
05475899190.
HH–4 Cell Culture Medium ....................................
HH–4 Cell Culture Medium ....................................
ADVIA Chemistry Drug CAL 1 ...............................
ADVIA Chemistry Drug CAL 1, Level 2 .................
ADVIA Chemistry Drug CAL 1, Level 3 .................
ADVIA Chemistry Drug CAL 1, Level 4 .................
ADVIA Chemistry Drug CAL 1, Level 5 .................
Bulk EII Plus THC CAL 2 ML ................................
Bulk EII Plus THC CAL 3 ML ................................
Bulk EII Plus THC CAL 4 ML ................................
Bulk EII Plus THC CAL 5 ML ................................
Bulk EII Plus THC Control 1 ML ............................
Bulk EII Plus THC Control 2 ML ............................
Bulk EII Plus THC Control 3 ML ............................
Bulk EII Plus THC Control 4 ML ............................
Bulk EII Plus THC Control 5 ML ............................
Bulk EII Plus THC Control 6 ML ............................
Dimension Drug Calibrator, Level 2 .......................
Dimension Drug Calibrator, Level 3 .......................
Dimension Drug Calibrator, Level 4 .......................
Dimension Drug Calibrator, Level 5 .......................
Dimension Clinical Chemistry System DRUG Calibrator.
Dimension Vista DRUG 1 CAL, B .........................
Dimension Vista Drug 4 CAL, Level B ..................
Dimension Vista Drug 4 CAL, Level C ..................
Dimension Vista Drug 4 CAL, Level D ..................
Dimension Vista Drug 4 CAL, Level E ..................
Dimension Vista LOCI 8 CAL ................................
Dimension Vista LOCI 9 CAL Levels A–E .............
Vials: 25 mL .......................................
5/31/2012
Box: 1 vial; 25 mL ..............................
5/31/2012
Vials: 25 mL .......................................
5/31/2012
Vial 5 mL; Box: 6 vials .......................
12/22/2011
Box: 6 vials; 5 mL each .....................
12/22/2011
Vial 5 mL; Box: 6 vials .......................
12/22/2011
Box: 6 vials; 5 mL each .....................
12/22/2011
Vial 5 mL; Box: 6 vials .......................
12/22/2011
Box: 6 vials; 5 mL each .....................
12/22/2011
Ampule: 2 mL .....................................
Ampule: 2 mL .....................................
Ampule: 2 mL .....................................
Ampule: 2 mL .....................................
Ampule: 2 mL .....................................
Ampule: 2 mL .....................................
Ampule: 2 mL .....................................
Glass vial: 5 mL .................................
Glass vial: 5 mL .................................
Box of 6 vials, 10 mL each ................
12/22/2011
12/22/2011
12/22/2011
7/5/2012
2/1/2012
12/22/2011
5/31/2012
7/31/2012
7/31/2012
7/31/2012
Box of 6 vials, 10 mL each ................
7/31/2012
Box of 4 vials, 5 mL each ..................
7/31/2012
Box of 6 vials, 5 mL each ..................
7/31/2012
Box of 6 vials, 5 mL each ..................
7/31/2012
Bag: 1L, 200L, 500L; Bottle: 1L, 2L ..
Bag: 20 L, 100L, 1,000 L ...................
Carton: 10 vials; 3 ml each ................
Vial: 3 mL ...........................................
Vial: 3 mL ...........................................
Vial: 3 mL ...........................................
Vial: 3 mL ...........................................
Bulk Container: 4 mL–100 L ..............
Bulk Container: 4 mL–100 L ..............
Bulk Container: 4 mL–100 L ..............
Bulk Container: 4 mL–100 L ..............
Bulk Container: 4 mL–100 L ..............
Bulk Container: 4 mL–100 L ..............
Bulk Container: 4 mL–100 L ..............
Bulk Container: 4 mL–100 L ..............
Bulk Container: 4 mL–100 L ..............
Bulk Container: 4 mL–100 L ..............
Vial: 2.5 mL ........................................
Vial: 2.5 mL ........................................
Vial: 2.5 mL ........................................
Vial: 2.5 mL ........................................
Carton: 10 vials; 2.5 ml each .............
2/3/2012
3/22/2012
11/5/2012
11/5/2012
11/5/2012
11/5/2012
11/5/2012
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
11/5/2012
11/5/2012
11/5/2012
11/5/2012
11/5/2012
Vial: 2.5 mL ........................................
Vial: 3 mL ...........................................
Vial: 3 mL ...........................................
Vial: 3 mL ...........................................
Vial: 3 mL ...........................................
Box of 10 vials; Vial: 2.5 mL ..............
Vial: 1.5 mL ........................................
7/31/2012
11/5/2012
11/5/2012
11/5/2012
11/5/2012
3/22/2012
12/22/2011
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Microgenics Corporation ....................
Restek Corporation ............................
Restek Corporation ............................
Restek Corporation ............................
Restek Corporation ............................
Restek Corporation ............................
Restek Corporation ............................
Restek Corporation ............................
Roche Diagnostics Operations, Inc ...
Roche Diagnostics Operations, Inc ...
Roche Diagnostics Operations, Inc ...
Roche Diagnostics Operations, Inc ...
Roche Diagnostics Operations, Inc ...
Roche Diagnostics Operations, Inc ...
Roche Diagnostics Operations, Inc ...
tkelley on DSK3SPTVN1PROD with
SAFC Biosciences .............................
SAFC Biosciences .............................
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens
Siemens
Siemens
Siemens
Siemens
Siemens
Siemens
Healthcare
Healthcare
Healthcare
Healthcare
Healthcare
Healthcare
Healthcare
VerDate Mar<15>2010
Diagnostics
Diagnostics
Diagnostics
Diagnostics
Diagnostics
Diagnostics
Diagnostics
18:11 Jan 18, 2013
Inc
Inc
Inc
Inc
Inc
Inc
Inc
Jkt 229001
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
E:\FR\FM\22JAN1.SGM
22JAN1
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
4455
CHART I—Continued
Supplier
Product name
Form
Exemption
date
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthcare Diagnostics Inc
Supelco, Inc .......................................
Ultra Scientific, Inc .............................
Ultra Scientific, Inc .............................
Dimension Vista System DRUG 1 CAL .................
Dimension Vista System Drug 4 CAL ....................
Dimension Vista System LOCI 9 Calibrator ..........
Dimension Vista UDAT CAL ..................................
Dimension Vista UDAT CAL Bulk, Level B ...........
Dimension Vista UDAT CAL Pilot, Level B ...........
Dimension Vista UDAT CAL, Level B ....................
FC EII Plus THC CAL 2 ML ...................................
FC EII Plus THC CAL 3 ML ...................................
FC EII Plus THC CAL 4 ML ...................................
FC EII Plus THC CAL 5 ML ...................................
FC EII Plus THC Control 1 ML ..............................
FC EII Plus THC Control 2 ML ..............................
FC EII Plus THC Control 3 ML ..............................
FC EII Plus THC Control 4 ML ..............................
FC EII Plus THC Control 5 ML ..............................
FC EII Plus THC Control 6 ML ..............................
MP LOCI 9 TTST Cal Lvl 1–7 FC .........................
MP LOCI 9 TTST Lvl 1–7 Bulk ..............................
VS Drug 1 Cal Bulk Soln, Level B .........................
VS LOCI 9 CAL BULK SOLN Levels 1–5 .............
VS LOCI CAL 8 BULK SOLN Level 2 ...................
VS LOCI CAL 8 BULK SOLN Level 3 ...................
VS LOCI CAL 8 BULK SOLN Level 4 ...................
VS LOCI CAL 8 BULK SOLN Level 5 ...................
VS LOCI CAL 8 Vial Level E .................................
VS LOCI CAL 8 Vial Level B .................................
VS LOCI CAL 8 Vial Level C .................................
VS LOCI CAL 8 Vial Level D .................................
Custom Mix, 0.2–163.2 μg/mL in methanol ...........
DSA Detection Cocaine HCl Standard ..................
DSA
Detection
Cocaine
HCl
StandardPhenobarbital (625 μg/mL).
DSA
Detection
Cocaine
HCl
StandardPhenobarbital (6400 μg/mL).
GE-Ion Track 100 ng/μL TNT/Cocaine HCl Standard Rev. 1.
GE-Ion Track 100 ng/μL TNT/Cocaine HCl Standard Rev. 1.
Phenobarbital (625 μg/mL) ....................................
Phenobarbital (6400 μg/mL) ..................................
Ultracheck WS Chloral Hydrate Sample ................
Carton: 6 vials; 2.5 mL each .............
Carton: 10 vials; 3 ml each ................
Box of 10 vials; Vial: 1.5 mL ..............
Glass vial: 3 mL; Carton: 6 vials .......
Bulk Container: 20 L–25 L .................
Pilot Container: 2 mL–125 mL ...........
Glass vial: 3 mL .................................
Plastic vial: 15 mL ..............................
Plastic vial: 15 mL ..............................
Plastic vial: 15 mL ..............................
Plastic vial: 15 mL ..............................
Plastic vial: 15 mL ..............................
Plastic vial: 15 mL ..............................
Plastic vial: 15 mL ..............................
Plastic vial: 15 mL ..............................
Plastic vial: 15 mL ..............................
Plastic vial: 15 mL ..............................
Vial: 1–5 mL .......................................
Bulk container: 4 mL–100 L ...............
Bulk container: 2 mL–1 L ...................
Bulk container: 4 mL–100 L ...............
Bulk container: 4 mL–100 L ...............
Bulk container: 4 mL–100 L ...............
Bulk container: 4 mL–100 L ...............
Bulk container: 4 mL–100 L ...............
Vial: 2.5 mL ........................................
Vial: 2.5 mL ........................................
Vial: 2.5 mL ........................................
Vial: 2.5 mL ........................................
Glass ampule: 1 mL ...........................
Amber ampule: 1 mL .........................
Amber ampule: 1 mL .........................
7/31/2012
11/5/2012
12/22/2011
12/22/2011
5/31/2012
5/31/2012
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
7/31/2012
12/22/2011
3/22/2012
3/22/2012
3/22/2012
3/22/2012
3/22/2012
3/22/2012
3/22/2012
3/22/2012
7/31/2012
12/22/2011
12/22/2011
Amber ampule: 1 mL .........................
12/22/2011
Amber ampule: 10 mL .......................
12/22/2011
Glass bottle: 100 mL ..........................
12/22/2011
Amber ampule: 1 mL .........................
Amber ampule: 1 mL .........................
Glass ampule: 2 mL ...........................
5/31/2012
5/31/2012
12/22/2011
Ultra Scientific, Inc .............................
Ultra Scientific, Inc .............................
Ultra Scientific, Inc .............................
Ultra Scientific, Inc .............................
Ultra Scientific, Inc .............................
Ultra Scientific, Inc .............................
The Deputy Assistant Administrator
has found that each of the compounds,
mixtures, and preparations described in
Chart II below is not consistent with the
criteria stated in 21 U.S.C. 811(g)(3)(B)
and in 21 CFR 1308.23. Accordingly, the
Deputy Assistant Administrator has
determined that the chemical
preparations or mixtures generally
described in Chart II below and
specifically described in the application
materials received by DEA, are not
exempt from application of the CSA or
from application of the CFR, with regard
to the requested exemption pursuant to
21 CFR 1308.23, as of the date listed
below that was provided in the
determination letters to the individual
requesters.
CHART II
Product name
Form
Denial date
Abbott Laboratories ............................
Abbott Laboratories ............................
tkelley on DSK3SPTVN1PROD with
Supplier
ARCHITECT Estradiol Assay Diluent, No. 2K25J
AxSYM Estradiol Buffer .........................................
12/22/2011
12/22/2011
American Radiolabeled
Inc..
Biochemical Diagnostics,
Biochemical Diagnostics,
Biochemical Diagnostics,
Biochemical Diagnostics,
Biochemical Diagnostics,
Biochemical Diagnostics,
Biochemical Diagnostics,
Biochemical Diagnostics,
Lysergic acid diethylamide .....................................
Tank: 50–500 L ..................................
Bulk Tank: 50–500 L; Bag-in-box:
18–200 L.
Vial: 1 mL ...........................................
12/22/2011
Benzoylecgonine Bulk Solution (5 mg/mL) ............
Cocaine Bulk Solution(5 mg/mL) ...........................
Codeine Bulk Solution(5 mg/mL) ...........................
d-Amphetamine Bulk Solution (5 mg/mL) ..............
Detectabuse Custom Liquid Control Urine, MC134
Detectabuse Custom Liquid Control Urine, MC135
Detectabuse Custom Liquid Control Urine, MC136
Detectabuse Custom Liquid Control Urine, MC137
Bottle: 1 ml–1 L
Bottle: 1 ml–1 L
Bottle: 1 ml–1 L
Bottle: 1 ml–1 L
Glass vials: 500
Glass vials: 500
Glass vials: 200
Glass vials: 500
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
VerDate Mar<15>2010
Chemicals,
Inc.
Inc.
Inc.
Inc.
Inc.
Inc.
Inc.
Inc.
............
............
............
............
............
............
............
............
18:11 Jan 18, 2013
Jkt 229001
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
E:\FR\FM\22JAN1.SGM
..................................
..................................
..................................
..................................
ml–2 L .....................
ml–2 L .....................
ml–2 L .....................
ml–2 L .....................
22JAN1
4456
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
CHART II—Continued
Supplier
Product name
Form
Denial date
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Biochemical Diagnostics, Inc. ............
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Detectabuse Custom Liquid Control Urine, MC138
Detectabuse Custom Liquid Control Urine, MC139
Detectabuse Custom Liquid Control Urine, MC140
Detectabuse Custom Liquid Control Urine, MC141
Detectabuse Custom Liquid Control Urine, MC142
d-Methamphetamine Bulk Solution(5 mg/mL) .......
d-Propoxyphene Bulk Solution (5 mg/mL) .............
Hydrocodone Bulk Solution(5 mg/mL) ...................
Hydromorphone Bulk Solution(5 mg/mL) ...............
MDA Bulk Solution(5 mg/mL) ................................
MDEA Bulk Solution(5 mg/mL) ..............................
MDMA Bulk Solution(5 mg/mL) .............................
Methadone Bulk Solution(5 mg/mL) ......................
Methaqualone Bulk Solution(5 mg/mL) ..................
Morphine Bulk Solution (5 mg/mL) ........................
Oxazepam Bulk Solution (5 mg/mL) ......................
Secobarbital Bulk Solution (5 mg/mL) ...................
Liquichek Urine Toxicology Control C1 Minipak ....
Liquichek Urine Toxicology Control C2 Minipak ....
Liquichek Urine Toxicology Control C3 Minipak ....
Liquichek Urine Toxicology Control C4 Minipak ....
Liquichek Urine Toxicology Control Low Opiate
Level C2 Minipak.
Liquichek Urine Toxicology Control Low Opiate
Level C3 Minipak.
Liquichek Urine Toxicology Control S1 Minipak ....
Liquichek Urine Toxicology Control S1E Low Opiate Minipak.
Liquichek Urine Toxicology Control S1E Minipak ..
Liquichek Urine Toxicology Control S1S Minipak ..
Liquichek Urine Toxicology Control S2 Minipak ....
Liquichek Urine Toxicology Control S2E Low Opiate Minipak.
Liquichek Urine Toxicology Control S2E Minipak ..
Liquichek Urine Toxicology Control S2SMinipak ...
Liquichek Urine Toxicology Control S3 Minipak ....
4-Methylmethcathinone (hydrochloride), 10 mg in
1 mL Methanol.
4-Methylmethcathinone (hydrochloride), 25 mg in
2.5 mL Methanol.
4-Methylmethcathinone (hydrochloride), 5 mg in
500 μL Methanol.
5-methoxy DMT, 10 mg in 1 mL Methanol ............
5-methoxy DMT, 25 mg in 2.5 mL Methanol .........
5-methoxy DMT, 5 mg in 500 μL Methanol ...........
Methylenedioxy Pyrovalerone (hydrochloride), 10
mg in 1 mL Methanol.
Methylenedioxy Pyrovalerone (hydrochloride), 25
mg in 2.5 mL Methanol.
Methylenedioxy Pyrovalerone (hydrochloride), 5
mg in 500 μL Methanol.
Methylenedioxy Pyrovalerone, 10 mg in 1 mL
Methanol.
Methylenedioxy Pyrovalerone, 25 mg in 2.5 mL
Methanol.
Methylenedioxy Pyrovalerone, 5 mg in 500 μL
Methanol.
Methylenedioxy Pyrovalerone-d8 (hydrochloride),
10 mg in 1 mL Methanol.
Methylenedioxy Pyrovalerone-d8 (hydrochloride),
25 mg in 2.5 mL Methanol.
Methylenedioxy Pyrovalerone-d8 (hydrochloride),
5 mg in 500 μL Methanol.
Methylone (hydrochloride), 10 mg in 1 mL Methanol.
Methylone (hydrochloride), 25 mg in 2.5 mL Methanol.
Methylone (hydrochloride), 5 mg in 500 μL Methanol.
Codeine (1 mg/mL) ................................................
Codeine-D3 (1 mg/mL) ..........................................
Drug Solution # 16 .................................................
Glass vials: 500 ml–2 L .....................
Glass vials: 500 ml–2 L .....................
Glass vials: 500 ml–2 L .....................
Glass vials: 500 ml–2 L .....................
Glass vials: 1 ml–200 mL ..................
Bottle: 1 ml–1 L ..................................
Bottle: 1 ml–1 L ..................................
Bottle: 1 ml–1 L ..................................
Bottle: 1 ml–1 L ..................................
Bottle: 1 ml–1 L ..................................
Bottle: 1 ml–1 L ..................................
Bottle: 1 ml–1 L ..................................
Bottle: 1 ml–1 L ..................................
Bottle: 1 ml–1 L ..................................
Bottle: 1 ml–1 L ..................................
Bottle: 1 ml–1 L ..................................
Bottle: 1 ml–1 L ..................................
Amber Vial: 20mL ..............................
Amber Vial: 20mL ..............................
Amber Vial: 20mL ..............................
Amber Vial: 20mL ..............................
Amber Vial: 20mL ..............................
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
11/15/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
12/22/2011
Amber Vial: 20mL ..............................
12/22/2011
Amber Vial: 10mL ..............................
Amber Vial: 10mL ..............................
12/22/2011
12/22/2011
Amber
Amber
Amber
Amber
..............................
..............................
..............................
..............................
12/22/2011
12/22/2011
12/22/2011
12/22/2011
Amber Vial: 10mL ..............................
Amber Vial: 10mL ..............................
Amber Vial: 10mL ..............................
Glass vial: 1 mL .................................
12/22/2011
12/22/2011
12/22/2011
7/31/2012
Glass vial: 2.5 mL ..............................
7/31/2012
Glass vial: 500 μL ..............................
7/31/2012
Glass
Glass
Glass
Glass
1 mL .................................
2.5 mL ..............................
500 μL ..............................
1 mL .................................
7/31/2012
7/31/2012
7/31/2012
7/31/2012
Glass vial: 2.5 mL ..............................
7/31/2012
Glass vial: 500 μL ..............................
7/31/2012
Glass vial: 1 mL .................................
7/31/2012
Glass vial: 2.5 mL ..............................
7/31/2012
Glass vial: 500 μL ..............................
7/31/2012
Glass vial: 1 mL .................................
7/31/2012
Glass vial: 2.5 mL ..............................
7/31/2012
Glass vial: 500 μL ..............................
7/31/2012
Glass vial: 1 mL .................................
7/31/2012
Glass vial: 2.5 mL ..............................
7/31/2012
Glass vial: 500 μL ..............................
7/31/2012
Glass ampule: 5 mL ...........................
Glass ampule: 5 mL ...........................
Screw-cap Vial: 50 mL .......................
7/31/2012
7/31/2012
6/5/2012
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad
Bio-Rad
Bio-Rad
Bio-Rad
Laboratories
Laboratories
Laboratories
Laboratories
.........................
.........................
.........................
.........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Bio-Rad Laboratories .........................
Cayman Chemical Company .............
Cayman Chemical Company .............
Cayman Chemical Company .............
Cayman
Cayman
Cayman
Cayman
Chemical
Chemical
Chemical
Chemical
Company
Company
Company
Company
.............
.............
.............
.............
Cayman Chemical Company .............
Cayman Chemical Company .............
Cayman Chemical Company .............
Cayman Chemical Company .............
Cayman Chemical Company .............
Cayman Chemical Company .............
Cayman Chemical Company .............
Cayman Chemical Company .............
Cayman Chemical Company .............
tkelley on DSK3SPTVN1PROD with
Cayman Chemical Company .............
Cayman Chemical Company .............
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
VerDate Mar<15>2010
18:11 Jan 18, 2013
Jkt 229001
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
Vial:
Vial:
Vial:
Vial:
vial:
vial:
vial:
vial:
E:\FR\FM\22JAN1.SGM
10mL
10mL
10mL
10mL
22JAN1
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
4457
CHART II—Continued
Product name
Form
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Cerilliant Corporation .........................
Environmental Resource Associates
(ERA).
Environmental Resource Associates
(ERA).
Immunalysis Corporation ...................
Immunalysis Corporation ...................
Immunalysis Corporation ...................
Restek Corporation ............................
Restek Corporation ............................
Siemens Healthcare Diagnostics Inc.
Siemens Healthcare Diagnostics Inc.
Siemens Healthcare Diagnostics Inc.
Siemens Healthcare Diagnostics Inc.
Siemens Healthcare Diagnostics Inc.
Siemens Healthcare Diagnostics Inc.
Siemens Healthcare Diagnostics Inc.
tkelley on DSK3SPTVN1PROD with
Supplier
Drug Solution # 17 .................................................
Drug Solution # 18 .................................................
Drug Solution # 19 .................................................
Drug Solution # 20 .................................................
Hydrocodone (1 mg/mL) ........................................
Hydrocodone-D6 (1 mg/mL) ..................................
Hydromorphone (1 mg/mL) ....................................
Hydromorphone-D3 (1 mg/mL) ..............................
Morphine (1 mg/mL) ...............................................
Morphine-D3 (1 mg/mL) .........................................
Noroxycodone HCl (1 mg/mL) ...............................
Noroxycodone-D3 HCl (1 mg/mL) .........................
Oxycodone (1 mg/mL) ...........................................
Oxycodone-D3 (1 mg/mL) ......................................
Oxymorphone (1 mg/mL) .......................................
Oxymorphone-D3 (1 mg/mL) .................................
USGS BQS LS4434 Mix 1 .....................................
Screw-cap Vial: 50 mL .......................
Screw-cap Vial: 50 mL .......................
Screw-cap Vial: 50 mL .......................
Screw-cap Vial: 50 mL .......................
Glass ampule: 5 mL ...........................
Glass ampule: 5 mL ...........................
Glass ampule: 5 mL ...........................
Glass ampule: 5 mL ...........................
Glass ampule: 5 mL ...........................
Glass ampule: 5 mL ...........................
Glass ampule: 5 mL ...........................
Glass ampule: 5 mL ...........................
Glass ampule: 5 mL ...........................
Glass ampule: 5 mL ...........................
Glass ampule: 5 mL ...........................
Glass ampule: 5 mL ...........................
Glass Ampule: 1–2 mL ......................
6/5/2012
6/5/2012
6/5/2012
6/5/2012
7/31/2012
7/31/2012
7/31/2012
7/31/2012
7/31/2012
7/31/2012
7/31/2012
7/31/2012
7/31/2012
7/31/2012
7/31/2012
7/31/2012
7/31/2012
USGS BQS LS4434 Mix 2 .....................................
Glass Ampule: 1–2 mL ......................
7/31/2012
Tapentadol Calibrator Levels 1–4 ..........................
Tapentadol High Control ........................................
Tapentadol Low Control .........................................
Custom Cannabinoids Standard ............................
Custom Paraldehyde Standard (10 mg/mL) ..........
Dimension Vista UDAT CAL Bulk, Level B ...........
Dimension Vista UDAT CAL Bulk, Level B ...........
Drug CAL BULK SOLN, Level 2 ............................
Drug CAL BULK SOLN, Level 3 ............................
Drug CAL BULK SOLN, Level 4 ............................
Drug CAL BULK SOLN, Level 5 ............................
VS Drug 1 Cal Bulk Soln, Level B .........................
Glass vial: 10 mL ...............................
Glass vial: 10 mL ...............................
Glass vial: 10 mL ...............................
Ampule: 2 mL .....................................
Ampule: 2 mL .....................................
Bulk Container: 4mL–100L ................
Bulk Container: 26 L–50L ..................
Bulk container: 2 L–100 L ..................
Bulk container: 2 mL–100 L ...............
Bulk container: 2 mL–100 L ...............
Bulk container: 2m L–100 L ...............
Bulk container: 2 mL–100 L ...............
6/19/2012
6/19/2012
6/19/2012
5/31/2012
7/5/2012
12/22/2011
5/31/2012
11/5/2012
11/5/2012
11/5/2012
11/5/2012
7/31/2012
Scope of Approval
The exemptions are applicable only to
the precise preparation or mixture
described in the application submitted
to DEA in the form(s) listed in this
order. Pursuant to 21 CFR 1308.24(h),
any change in the quantitative or
qualitative composition of the
preparation or mixture or change in the
trade name or other designation of the
preparation or mixture after the date of
application requires a new application.
Pursuant to 21 CFR 1308.24(g), DEA
may prescribe requirements other than
those set forth in 1308.24(b)–(e) on a
case-by-case basis for materials
exempted in bulk quantities.
Accordingly, in order to limit
opportunity for diversion from the
larger bulk quantities, DEA has
determined that each of the exempted
bulk products listed in this order may
only be used in-house and may not be
transported to other facilities.
Additional exempt chemical
preparation requests received between
June 12, 2011, and June 30, 2012, and
not otherwise referenced in this order
may remain pending until DEA receives
additional information required,
pursuant to 21 CFR 1308.23(d), as
detailed in separate correspondence to
individual requesters. DEA’s order on
VerDate Mar<15>2010
18:11 Jan 18, 2013
Jkt 229001
such requests will be published in a
future Federal Register.
Chemical Preparations Containing
Newly Controlled Substances
The statutory authority for exempt
chemical preparations is based on the
control status of substances contained
within a preparation, the intended
administration of a preparation, and the
packaged form of a preparation. DEA
conducts a case-by-case analysis of each
application for exemption to determine
whether exemption of a preparation
from certain provisions of the CSA is
appropriate pursuant to the specified
statutory and regulatory requirements.
Most exempt chemical preparations
have remained effective indefinitely
unless the holder of a specific exempt
chemical preparation specifically
requested that the exemption be
terminated. The CSA allows for
modifications to the controlled
substances schedules to add, remove, or
change the schedule of substances thus
resulting in periodic modifications to
the control status of various substances.
21 U.S.C. 811(a). Since the CSA was
enacted in 1970, DEA has on several
occasions added to, removed from, or
modified the schedules of controlled
substances in accordance with the CSA.
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Denial date
Such changes may result in the noncompliance of exempt chemical
preparations with current statutes or
regulations if chemical preparations that
have already obtained exempt status
contain newly controlled substances.
For example, although an exempt
chemical preparation may continue to
be packaged in the same manner as
when it was approved, non-controlled
substances in the preparation may
become controlled, thus prompting the
need for a new application for
exemption of the chemical preparation
to ensure continued compliance. Other
preparations that previously contained
no controlled substances may contain
newly controlled substances and thus
would require an application for
exemption.
DEA reviews applications for
chemical preparation exemptions based
on the statutes and regulations that are
in place at the time of the application,
including the control status of
substances included in the preparation.
DEA must remain vigilant to ensure that
exempt chemical preparations remain
consistent with the standards set forth
in the CSA and its implementing
regulations. As such, DEA reminds the
public that any chemical preparation,
regardless of whether it was previously
E:\FR\FM\22JAN1.SGM
22JAN1
4458
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
exempt, that contains a newly
controlled substance will require a new
application for exemption pursuant to
21 U.S.C. 811(g)(3)(B) and 21 CFR
1308.23–1308.24.
Review of Exemptions Pursuant to 21
U.S.C. 811(g)(3)
Based on inquiries received from
industry, DEA is conducting a
comprehensive review of the exempt
chemical preparation regulations. DEA’s
regulations at 21 CFR 1308.24(a) state
that approved chemical preparations are
exempt from certain provisions of both
Subchapter I and Subchapter II of the
CSA: ‘‘The chemical preparations and
mixtures approved pursuant to 1308.23
are exempt from application of sections
302, 303, 305, 306, 307, 308, 309, 1002,
1003 and 1004 of the Act (21 U.S.C.
822–823, 825–829, 952–954) and
1301.74 of this chapter, to the extent
described in paragraphs (b) to (h) of this
section.’’ Pursuant to its regulations,
DEA has provided exemptions from the
application of section 302, 303, 305,
306, 307, 308, 309, 1002, 1003, and 1004
of the Act (21 U.S.C. 822–823, 825–829,
952–954) and 21 CFR 1301.74 since the
implementation of the regulations in the
early 1970s. Until DEA’s analysis of the
exemption regulations is complete, DEA
will continue to review and provide
exemptions to chemical preparations
consistent with the implementing
regulations, when warranted. DEA will
publish a future notice regarding the
outcome of DEA’s review of its
regulations with respect to the
exemption of chemical preparations.
Request for Comment
Pursuant to 21 CFR 1308.23, any
interested person may submit written
comments on or objections to any
chemical preparation in this order that
has been approved or denied as exempt.
If any comments or objections raise
significant issues regarding any finding
of fact or conclusion of law upon which
this order is based, the Deputy Assistant
Administrator will immediately
suspend the effectiveness of any
applicable part of this order until he
may reconsider the application in light
of the comments and objections filed.
tkelley on DSK3SPTVN1PROD with
Approved Exempt Chemical
Preparations Are Posted on DEA’s Web
site
A list of all current exemptions,
including those listed in this order, is
available on DEA’s Web site at https://
www.deadiversion.usdoj.gov/schedules/
exempt/exempt_chemlist.pdf. The dates
of applications of all current exemptions
are posted for easy reference.
VerDate Mar<15>2010
18:11 Jan 18, 2013
Jkt 229001
Dated: January 14, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2013–01133 Filed 1–18–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Employee Benefits Security
Administration
Proposed Information Collection
Request Submitted for Public
Comment; Survey Regarding Pension
Benefit Statements
Employee Benefits Security
Administration, Department of Labor.
ACTION: Notice.
AGENCY:
The Department of Labor (the
Department), in accordance with the
Paperwork Reduction Act of 1995 (PRA
95) (44 U.S.C. 3506(c)(2)(A)), provides
the general public and Federal agencies
with an opportunity to comment on
proposed and continuing collections of
information. This helps the Department
assess the impact of its information
collection requirements and minimize
the public’s reporting burden. It also
helps the public understand the
Department’s information collection
requirements and provide the requested
data in the desired format. The
Employee Benefits Security
Administration (EBSA) is soliciting
comments on the proposed information
collection request (ICR) described
below. A copy of the ICRs may be
obtained by contacting the office listed
in the ADDRESSES section of this notice.
ICRs also are available at reginfo.gov
(https://www.reginfo.gov/public/do/
PRAMain).
DATES: Written comments must be
submitted to the office shown in the
Addresses section on or before March
25, 2013.
ADDRESSES: G. Christopher Cosby,
Department of Labor, Employee Benefits
Security Administration, 200
Constitution Avenue NW., N–5718,
Washington, DC 20210, (202) 693–8410,
FAX (202) 693–4745 (these are not tollfree numbers).
SUMMARY:
I. Supplementary Information
This notice requests public comment
on the Department’s proposed collection
of information regarding a survey and
focus groups that will ask respondents
to answer questions related to
information presented in benefit
statements received from their
retirement plans. A summary of the ICR
and the current burden estimates
follows:
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
Agency: Employee Benefits Security
Administration, Department of Labor.
Title: Household survey questions and
experiments related to pension benefit
statements.
Type of Review: New collection of
information.
OMB Number: 1210–NEW.
Respondents: 2,950.
Number of Annual Responses: 2,950.
Total Burden Hours: 945 hours.
Total Annualized Capital/Startup
Costs: $0.
Total Annual Costs: $244,800.
Description: The Department is
planning to survey participants in an
existing household Internet panel called
the American Life Panel (ALP) and
conduct four focus groups consisting of
non-panel members to explore whether
information presented in retirement
plan benefit statements can be presented
in a manner that is understandable for
participants and beneficiaries and
makes them better prepared for
retirement. Topics probed in the survey
include participants’ current allocations
to their retirement accounts, their
expectations for how long they will
need to keep working, their financial
goals for retirement, the basis for
calculating those goals, how frequently
they view their current benefits
statement, whether they receive benefit
statements in paper or electronic format,
and what information from the
statements do they primarily focus on.
Survey participants will then be
provided with two different benefits
statements that provide slightly
different information and will be asked
to answer several questions based on
those statements to better assess what
they understand about the statements.
The study results will be used to
support the Department’s rulemaking
pursuant to section 105(a) of the
Employee Retirement Income Security
Act of 1974 as amended by the Pension
Protection Act of 2006, which requires
administrators of ERISA-covered
individual account plans to furnish
periodic benefit statements to
participants and beneficiaries and the
Department to develop model benefits
statements.
II. Focus of Comments
The Department is particularly
interested in comments that:
• Evaluate whether the collections of
information are necessary for the proper
performance of the functions of the
agency, including whether the
information will have practical utility;
• Evaluate the accuracy of the
agency’s estimate of the collections of
information, including the validity of
the methodology and assumptions used;
E:\FR\FM\22JAN1.SGM
22JAN1
Agencies
[Federal Register Volume 78, Number 14 (Tuesday, January 22, 2013)]
[Notices]
[Pages 4446-4458]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-01133]
[[Page 4446]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-361]
Exempt Chemical Preparations Under the Controlled Substances Act
AGENCY: Drug Enforcement Administration (DEA), Department of Justice.
ACTION: Order with opportunity for comment.
-----------------------------------------------------------------------
SUMMARY: The applications for exempt chemical preparations received by
DEA between June 12, 2011, and June 30, 2012, as listed below, were
accepted for filing and have been approved or denied as indicated.
DATES: Electronic comments must be submitted and written comments must
be postmarked on or before March 25, 2013. Commenters should be aware
that the electronic Federal Docket Management System will not accept
comments after midnight Eastern Time on the last day of the comment
period.
ADDRESSES: To ensure proper handling of comments, please reference
``Docket No. DEA-361'' on all electronic and written correspondence.
DEA encourages that all comments be submitted electronically through
https://www.regulations.gov using the electronic comment form provided
on that site. An electronic copy of this document is also available at
the https://www.regulations.gov Web site for easy reference. Paper
comments that duplicate the electronic submission are not necessary as
all comments submitted to www.regulations.gov will be posted for public
review and are part of the official docket record. Written comments
submitted via regular or express mail should be sent to the Drug
Enforcement Administration, Attention: DEA Federal Register
Representative/ODL, 8701 Morrissette Drive, Springfield, Virginia
22152.
FOR FURTHER INFORMATION CONTACT: John W. Partridge, Executive
Assistant, Office of Diversion Control, Drug Enforcement
Administration; Mailing Address: 8701 Morrissette Drive, Springfield,
Virginia 22152. Telephone: (202) 307-7165.
SUPPLEMENTARY INFORMATION:
Posting of Public Comments
Please note that all comments received are considered part of the
public record and made available for public inspection online at https://www.regulations.gov and in the DEA's public docket. Such information
includes personal identifying information (such as your name, address,
etc.) voluntarily submitted by the commenter.
If you want to submit personal identifying information (such as
your name, address, etc.) as part of your comment, but do not want it
to be posted online or made available in the public docket, you must
include the phrase ``PERSONAL IDENTIFYING INFORMATION'' in the first
paragraph of your comment. You must also place all the personal
identifying information you do not want posted online or made available
in the public docket in the first paragraph of your comment and
identify what information you want redacted.
If you want to submit confidential business information as part of
your comment, but do not want it to be posted online or made available
in the public docket, you must include the phrase ``CONFIDENTIAL
BUSINESS INFORMATION'' in the first paragraph of your comment. You must
also prominently identify confidential business information to be
redacted within the comment. If a comment has so much confidential
business information that it cannot be effectively redacted, all or
part of that comment may not be posted online or made available in the
public docket.
Personal identifying information and confidential business
information identified and located as set forth above will be redacted,
and the comment, in redacted form, will be posted online and placed in
DEA's public docket file. Please note that the Freedom of Information
Act applies to all comments received. If you wish to inspect the
agency's public docket file in person by appointment, please see the
FOR FURTHER INFORMATION CONTACT paragraph.
SUPPLEMENTARY INFORMATION:
Legal Authority
DEA implements and enforces Titles II and III of the Comprehensive
Drug Abuse Prevention and Control Act of 1970, often referred to as the
Controlled Substances Act and the Controlled Substances Import and
Export Act (codified at Title 21, Chapter 13 of the U.S.C.), as amended
(hereinafter, ``CSA''). DEA drafts and publishes the implementing
regulations for these statutes in Title 21 of the Code of Federal
Regulations (CFR), parts 1300 to 1321. The CSA and its implementing
regulations are designed to prevent, detect, and eliminate the
diversion of controlled substances and listed chemicals into the
illicit market while providing for a sufficient supply of controlled
substances and listed chemicals for legitimate medical, scientific,
research, and industrial purposes. Controlled substances have the
potential for abuse and dependence and are controlled to protect the
public health and safety.
Section 201 of the CSA (21 U.S.C. 811) authorizes the Attorney
General, by regulation, to exempt from certain provisions of the CSA
certain compounds, mixtures, or preparations containing a controlled
substance, if he finds that such compounds, mixtures, or preparations
meet the requirements detailed in 21 U.S.C. 811(g)(3)(B).\1\ DEA
regulations at 21 CFR 1308.23 and 1308.24 further detail the criteria
by which the DEA Deputy Assistant Administrator may exempt a chemical
preparation or mixture from the application of certain provisions of
the CSA. The Deputy Assistant Administrator may, pursuant to 21 CFR
1308.23(f), modify or revoke the criteria by which exemptions are
granted and modify the scope of exemptions at any time.
---------------------------------------------------------------------------
\1\ This authority has been delegated from the Attorney General
to the Administrator of the DEA by 28 CFR 0.100 and subsequently
redelegated to the Deputy Assistant Administrator pursuant to the
Appendix to Subpart R of 28 CFR 0.104.
---------------------------------------------------------------------------
Exempt Chemical Preparation Applications Submitted Between June 12,
2011, and June 30, 2012
The Deputy Assistant Administrator received applications between
June 12, 2011, and June 30, 2012, requesting exempt chemical
preparation status pursuant to 21 CFR 1308.23. Pursuant to the criteria
stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Deputy
Assistant Administrator has found that each of the compounds, mixtures,
and preparations described in Chart I below is intended for laboratory,
industrial, educational, or special research purposes and not for
general administration to a human being or other animal and either: (1)
Contains no narcotic controlled substance and is packaged in such a
form or concentration that the packaged quantity does not present any
significant potential for abuse; or (2) contains either a narcotic or
non-narcotic controlled substance and one or more adulterating or
denaturing agents in such a manner, combination, quantity, proportion,
or concentration that the preparation or mixture does not present any
potential for abuse; if the preparation or mixture contains a narcotic
controlled substance, it must be formulated in such a manner that it
incorporates methods of denaturing or other means so that the
preparation or mixture is not liable to be abused or have ill effects
if abused, and so that the
[[Page 4447]]
narcotic substance cannot in practice be removed.
Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23,
and 21 CFR 1308.24, the Deputy Assistant Administrator has determined
that each of the chemical preparations or mixtures generally described
in Chart I below and specifically described in the application
materials received by DEA, are exempt from application of sections 302,
303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 (21 U.S.C. 822-823,
825-829, and 952-954) of the CSA and from application of 21 CFR
1301.74, to the extent described in 21 CFR 1308.24, as of the date
listed below that was provided in the approval letters to the
individual requesters.
Chart I
----------------------------------------------------------------------------------------------------------------
Exemption
Supplier Product name Form date
----------------------------------------------------------------------------------------------------------------
Abbott Laboratories.................... ARCHITECT 2nd Generation Bottle: 4 mL; Box: 6 12/22/2011
Testosterone Calibrators bottles.
(B,C,D,E,F).
Abbott Laboratories.................... ARCHITECT 2nd Generation Bottle: 8 mL; Box: 3 12/22/2011
Testosterone Controls (L,M,H). bottles.
Abbott Laboratories.................... ARCHITECT Estradiol Assay Bag-in-box: 18-200 L; 12/22/2011
Diluent, No. 2K25J. Flask/Carboy: 1-50 L;
Bottle/Vial: 0.5 mL-1 L;
Box: 1-50 bottles.
Abbott Laboratories.................... ARCHITECT Estradiol Assay Bottle: 5.9 mL........... 12/22/2011
Diluent, No. 7K72J.
Abbott Laboratories.................... ARCHITECT Estradiol Reagent Bottle: 5.9 mL; Kit: 16 12/22/2011
Kit, No. 07K72-20. bottles.
Abbott Laboratories.................... ARCHITECT Estradiol Reagent Bottle: 5.9 mL; Kit: 4 12/22/2011
Kit, No. 07K72-25. bottles.
Abbott Laboratories.................... ARCHITECT Estradiol Reagent Bottle: 5.9 mL; Kit: 16 12/22/2011
Kit, No. 2K25-20. bottles.
Abbott Laboratories.................... ARCHITECT Estradiol Reagent Bottle: 5.9 mL; Kit: 4 12/22/2011
Kit, No. 2K25-25. bottles.
Abbott Laboratories.................... AxSYM Estradiol Buffer......... Flask/Carboy: 1-50 L; 12/22/2011
Bottle/Vial: 0.5 mL-1 L;
Box: 1-50 bottles.
Abbott Laboratories.................... AxSYM Estradiol Reagent Pack... Bottle: 5.5 mL, Pack: 4 12/22/2011
bottles.
Agilent Technologies................... Special Order Standard TOXI-LAB Plastic Vial: 50 discs... 12/22/2011
DISCS; 1, 2, or 3 drugs.
Agilent Technologies................... Special Procedure Standard TOXI- Plastic Vial: 50 discs... 12/22/2011
LAB DISCS: Benzodiazepines:
Hydrolysis Procedure.
Agilent Technologies................... Special Procedure Standard TOXI- Plastic Vial: 50 discs... 12/22/2011
LAB DISCS: Benzoylecgonine.
Agilent Technologies................... Special Procedure Standard TOXI- Plastic Vial: 50 discs... 12/22/2011
LAB DISCS: MDMA, MDA, MDEA.
Agilent Technologies................... Special Procedure Standard TOXI- Plastic Vial: 50 discs... 12/22/2011
LAB DISCS: Morphine and
Hydromorphone: Differentiation.
Agilent Technologies................... Special Procedure Standard TOXI- Plastic Vial: 50 discs... 12/22/2011
LAB DISCS: Opiate.
Agilent Technologies................... Special Procedure Standard TOXI- Plastic Vial: 50 discs... 12/22/2011
LAB DISCS: Sympathomimetic
amines: Differentiation.
Agilent Technologies................... Special Standard TOXI-LAB DISCS Plastic Vial: 50 discs... 12/22/2011
LTD-Opiate: 1, 2, or 3 drugs.
Agilent Technologies................... TOXI-LAB Chromatograms A....... Glass jar: 100 12/22/2011
Chromatograms.
Agilent Technologies................... TOXI-LAB Chromatograms B....... Glass jar: 100 12/22/2011
Chromatograms.
Agilent Technologies................... TOXI-LAB CONTROL LTD FM........ Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB CONTROL No. 19........ Plastic bottle: 2 oz..... 12/22/2011
Agilent Technologies................... TOXI-LAB CONTROL No. 2......... Plastic bottle: 2 oz..... 12/22/2011
Agilent Technologies................... TOXI-LAB CONTROL No. 3......... Plastic bottle: 2 oz..... 12/22/2011
Agilent Technologies................... TOXI-LAB CONTROL No. 5......... Plastic bottle: 2 oz..... 12/22/2011
Agilent Technologies................... TOXI-LAB CONTROL THC........... Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB DISCS A-1............. Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB DISCS A-2............. Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB DISCS A-3............. Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB DISCS A-4............. Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB DISCS B-1............. Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB DISCS B-2............. Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB DISCS B-3............. Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB DISCS B-4............. Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB DISCS LTD HD.......... Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB DISCS LTD OP.......... Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB DISCS LTD OPI......... Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB DISCS THC............. Plastic vial: 50 discs... 12/22/2011
Agilent Technologies................... TOXI-LAB Proficiency Sample.... Plastic bottle: 2 oz..... 12/22/2011
American Radiolabeled Chemicals, Inc... (+)-iodo-Lysergic Acid Vial: 1 mL............... 12/22/2011
diethylamide [125I].
American Radiolabeled Chemicals, Inc... (+)-Pentazocine (1 mg/mL)...... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... (+)-Pentazocine [ring-1,3-3H].. Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... ()-Ketamine [N- Vial: 1 mL............... 12/22/2011
methyl-3H] hydrochloride.
[[Page 4448]]
American Radiolabeled Chemicals, Inc... ()-Ketamine Vial: 1 mL............... 12/22/2011
hydrochloride (1 mg/mL).
American Radiolabeled Chemicals, Inc... 1,1-Dimethyltryptamine (1 mg/ Vial: 1 mL............... 12/22/2011
mL).
American Radiolabeled Chemicals, Inc... 1,1-Dimethyltryptamine Vial: 1 mL............... 12/22/2011
[a,[beta]-3H] as TFA salt.
American Radiolabeled Chemicals, Inc... Amobarbital (1 mg/mL).......... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Amphetamine, D-[ring-2,3,5-3H] Vial: 1 mL............... 12/22/2011
hydrochloride.
American Radiolabeled Chemicals, Inc... Amphetamine, DL-[ring-2,3,5-3H] Vial: 1 mL............... 12/22/2011
hydrochloride.
American Radiolabeled Chemicals, Inc... Amphetamine, L-[ring-2,3,5-3H] Vial: 1 mL............... 12/22/2011
hydrochloride.
American Radiolabeled Chemicals, Inc... Buprenorphine [ring-3H] Vial: 1 mL............... 12/22/2011
hydrochloride.
American Radiolabeled Chemicals, Inc... Buprenorphine hydrochloride (1 Vial: 1 mL............... 12/22/2011
mg/mL).
American Radiolabeled Chemicals, Inc... Cocaine (1 mg/mL).............. Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Cocaine [methyl-14C] Vial: 1 mL............... 12/22/2011
hydrochloride.
American Radiolabeled Chemicals, Inc... Cocaine, levo-[benzoyl-3,4- Vial: 1 mL............... 12/22/2011
3H(N)].
American Radiolabeled Chemicals, Inc... Codeine (1 mg/mL).............. Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... D-Amphetamine hydrochloride (1 Vial: 1 mL............... 12/22/2011
mg/mL).
American Radiolabeled Chemicals, Inc... Dextropropoxyphene (1 mg/mL)... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Diazepam (1 mg/mL)............. Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Dihydrocodeine (1 mg/mL)....... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Dihydromorphine (1 mg/mL)...... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Diprenorphine (1 mg/mL)........ Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... DL-Amphetamine hydrochloride (1 Vial: 1 mL............... 12/22/2011
mg/mL).
American Radiolabeled Chemicals, Inc... D-Methamphetamine hydrochloride Vial: 1 mL............... 12/22/2011
(1 mg/mL).
American Radiolabeled Chemicals, Inc... Ecgonine (1 mg/mL)............. Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Fentanyl (1 mg/mL)............. Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Fentanyl [3H(G)] as TFA salt... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Fludiazepam (1 mg/mL).......... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Flunitrazepam (1 mg/mL)........ Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Flunitrazepam [methyl-3H]...... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Flurazepam (1 mg/mL)........... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Flurazepam [N-methyl-3H]....... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Heroin (1 mg/mL)............... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Heroin [methyl-14C]............ Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Heroin [methyl-3H]............. Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Hydrocodone (1 mg/mL).......... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Hydromorphone (1 mg/mL)........ Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Hydromorphone [N-methyl-14C] Vial: 1 mL............... 12/22/2011
hydrochloride.
[[Page 4449]]
American Radiolabeled Chemicals, Inc... Ibogaine (1 mg/mL)............. Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... L-Amphetamine hydrochloride (1 Vial: 1 mL............... 12/22/2011
mg/mL).
American Radiolabeled Chemicals, Inc... L-Methamphetamine hydrochloride Vial: 1 mL............... 12/22/2011
(1 mg/mL).
American Radiolabeled Chemicals, Inc... Lysergic Acid (1 mg/mL)........ Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Lysergic acid diethylamide [N- Vial: 1 mL............... 3/22/2012
methyl-3H].
American Radiolabeled Chemicals, Inc... Mazindol (1 mg/mL)............. Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Meperidine Hydrochloride (1 mg/ Vial: 1 mL............... 12/22/2011
mL).
American Radiolabeled Chemicals, Inc... Metazocine (1 mg/mL)........... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Metazocine [ring-1,3-3H]....... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Methamphetamine, D-[methyl-14C] Vial: 1 mL............... 12/22/2011
hydrochloride.
American Radiolabeled Chemicals, Inc... Methamphetamine, L-[methyl-14C] Vial: 1 mL............... 12/22/2011
hydrochloride.
American Radiolabeled Chemicals, Inc... Midazolam (1 mg/mL)............ Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Midazolam [3H(G)].............. Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Morphine (1 mg/mL)............. Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Morphine [N-methyl-14C]........ Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Normorphine (1 mg/mL).......... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Oripavine (1 mg/mL)............ Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Oxycodone [N-methyl-14C] Vial: 1 mL............... 12/22/2011
hydrochloride.
American Radiolabeled Chemicals, Inc... Oxycodone hydrochloride (1 mg/ Vial: 1 mL............... 12/22/2011
mL).
American Radiolabeled Chemicals, Inc... Oxymorphone (1 mg/mL).......... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Phenazocine (1 mg/mL).......... Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Phencyclidine hydrochloride (1 Vial: 1 mL............... 12/22/2011
mg/mL).
American Radiolabeled Chemicals, Inc... Phenylacetone (1 mg/mL)........ Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Tetrahydrocannabidinol (1 mg/ Vial: 1 mL............... 12/22/2011
mL).
American Radiolabeled Chemicals, Inc... Thebaine (1 mg/mL)............. Vial: 1 mL............... 12/22/2011
American Radiolabeled Chemicals, Inc... Thebaine [N-methyl-14C] Vial: 1 mL............... 12/22/2011
hydrochloride.
American Radiolabeled Chemicals, Inc... Thebaine [N-methyl-3H] Vial: 1 mL............... 12/22/2011
hydrochloride.
American Radiolabeled Chemicals, Inc... Thebaine [O-methyl-14C] Vial: 1 mL............... 12/22/2011
hydrochloride.
American Radiolabeled Chemicals, Inc... Thebaine [O-methyl-3H] Vial: 1 mL............... 12/22/2011
hydrochloride.
American Radiolabeled Chemicals, Inc... [gamma]-Hydroxybutyric acid Vial: 1 mL............... 12/22/2011
sodium salt (1 mg/mL).
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF10.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF11.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF12.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF13.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF14.
[[Page 4450]]
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF15.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF16.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF17.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF18.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF19.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/31/2012
Control Oral Fluid, OF20.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/31/2012
Control Oral Fluid, OF21.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF4.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF5.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF6.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF8.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Oral Fluid, OF9.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 11/15/2011
Control Urine, MC134.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 11/15/2011
Control Urine, MC135.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-100 mL. 11/15/2011
Control Urine, MC136.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 11/15/2011
Control Urine, MC137.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 11/15/2011
Control Urine, MC138.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 11/15/2011
Control Urine, MC139.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 11/15/2011
Control Urine, MC140.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 11/15/2011
Control Urine, MC141.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 2/1/2012
Control Urine, MC143.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 3/8/2012
Control Urine, MC144.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 3/8/2012
Control Urine, MC145.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 3/8/2012
Control Urine, MC146.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 3/8/2012
Control Urine, MC147.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 3/8/2012
Control Urine, MC148.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 3/22/2012
Control Urine, MC149.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Urine, MC150.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC151.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC152.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC153.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC154.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC155.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC156.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC157.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC158.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC159.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC160.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC161.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC162.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC163.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC164.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC165.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC166.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC167.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC168.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC169.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 8/20/2012
Control Urine, MC170.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Urine, MC171.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/31/2012
Control Urine, MC172.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/31/2012
Control Urine, MC173.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 2/1/2012
Control Urine, SD10.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 2/1/2012
Control Urine, SD11.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 2/1/2012
Control Urine, SD12.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 2/1/2012
Control Urine, SD13.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 2/1/2012
Control Urine, SD14.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Urine, SD15.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 7/5/2012
Control Urine, SD16.
[[Page 4451]]
Bio-Rad Laboratories................... Liquichek Immunoassay Plus Amber Vial: 10 mL; Box: 12/22/2011
Control Levels 1, 2, and 3. 12 vials.
Bio-Rad Laboratories................... Liquichek Immunoassay Plus Amber Vial: 10 mL; Box: 12/22/2011
Control Trilevel. 12 vials.
Bio-Rad Laboratories................... Liquichek Immunoassay Plus Amber Vial: 5 mL; Box: 3 12/22/2011
Control Trilevel Minipak. vials.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Box: 10 vials, 10 mL each 5/31/2012
Control S10.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Box: 10 vials, 10 mL each 5/31/2012
Control S10 Low Opiate.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber vial: 10 mL........ 5/31/2012
Control S10 Low Opiate Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber vial: 10 mL........ 5/31/2012
Control S10 Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Box: 10 vials, 10 mL each 5/31/2012
Control S20.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Box: 10 vials, 10 mL each 5/31/2012
Control S20 Low Opiate.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber vial: 10 mL........ 5/31/2012
Control S20 Low Opiate Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber vial: 10 mL........ 5/31/2012
Control S20 Minipak.
Bio-Rad Laboratories................... Liquid Assayed Multiqual Levels Amber Vial: 2.5 mL; Box: 12/22/2011
1-3. 12 vials.
Bio-Rad Laboratories................... Liquid Assayed Multiqual Amber Vial: 2.5 mL; Box: 12/22/2011
Trilevel MiniPak. 3 vials.
Bio-Rad Laboratories................... Liquid Unassayed Multiqual Amber Vial: 2.5 mL; Box: 12/22/2011
Levels 1-3. 12 vials.
Bio-Rad Laboratories................... Liquid Unassayed Multiqual Amber Vial: 2.5 mL; Box: 12/22/2011
Trilevel MiniPak. 3 vials.
Bio-Rad Laboratories................... Lyphochek Assayed Chemistry Box 2 vials; 5 mL each... 12/22/2011
Control Bilevel MiniPak.
Bio-Rad Laboratories................... Lyphochek Assayed Chemistry Amber Vial: 5 mL; Box: 12 12/22/2011
Control Levels 1-2. vials.
Bio-Rad Laboratories................... Lyphochek Immunoassay Plus Amber Vial: 10 mL; Box: 12/22/2011
Control Levels 1, 2, and 3. 12 vials.
Bio-Rad Laboratories................... Lyphochek Immunoassay Plus Amber Vial: 10 mL; Box: 12/22/2011
Control Trilevel. 12 vials.
Bio-Rad Laboratories................... Lyphochek Immunoassay Plus Amber Vial: 5 mL; Box: 3 12/22/2011
Control Trilevel Minipak. vials.
Bio-Rad Laboratories................... Lyphochek Unassayed Chemistry Box 2 vials; 5 mL each... 12/22/2011
Control (Human) Bilevel
MiniPak.
Bio-Rad Laboratories................... Lyphochek Unassayed Chemistry Amber Vial: 5 mL; Box: 25 12/22/2011
Control (Human) Levels 1-2. vials.
Cerilliant Corporation................. () Pentazocine-13C3 Glass Ampule: 2 mL....... 12/22/2011
(0.1 mg/mL).
Cerilliant Corporation................. ()-cis-11-Nor-9- Glass Ampule: 2 mL....... 12/22/2011
carboxy-delta9-THC-D3
glucuronide (0.1 mg/mL).
Cerilliant Corporation................. 3,4-Methylenedioxypyrovalerone Glass Ampule: 2 mL....... 12/22/2011
HCl (1 mg/mL).
Cerilliant Corporation................. 3,4-Methylenedioxypyrovalerone- Glass Ampule: 2 mL....... 12/22/2011
D8 HCl (0.1 mg/mL).
Cerilliant Corporation................. 3-Desmethylprodine (1 mg/mL)... Glass Ampule: 1 mL....... 7/31/2012
Cerilliant Corporation................. 3-Desmethylprodine HCl (1 mg/ Glass Ampule: 1 mL....... 7/31/2012
mL).
Cerilliant Corporation................. 6-alpha/beta-Hydroxyoxymorphone Glass Ampule: 2 mL....... 12/22/2011
(1 mg/mL).
Cerilliant Corporation................. 6-alpha/beta-Hydroxyoxymorphone- Glass Ampule: 2 mL....... 12/22/2011
D3 (0.1 mg/mL).
Cerilliant Corporation................. Buprenorphine N-oxide (1 mg/mL) Glass Ampule: 1 mL....... 12/22/2011
Cerilliant Corporation................. Cannabinol-D3 (0.1 mg/mL)...... Glass Ampule: 2 mL....... 12/22/2011
Cerilliant Corporation................. Carisoprodol (1 mg/mL)......... Glass Ampule: 2 mL....... 12/22/2012
Cerilliant Corporation................. Carisoprodol-D7 (0.1 mg/mL).... Glass Ampule: 2 mL....... 12/22/2012
Cerilliant Corporation................. Carisoprodol-D7 (1 mg/mL)...... Glass Ampule: 2 mL....... 7/31/2012
Cerilliant Corporation................. Cocaine N-oxide HCl (1 mg/mL).. Glass Ampule: 2 mL....... 12/22/2011
Cerilliant Corporation................. Cocaine N-oxide HCl (1 mg/mL).. Glass Ampule: 2 mL....... 3/8/2012
Cerilliant Corporation................. Cocaine N-oxide-D3 HCl (0.1 mg/ Glass Ampule: 2 mL....... 12/22/2011
mL).
Cerilliant Corporation................. Cocaine N-oxide-D3 HCl (0.1 mg/ Glass Ampule: 2 mL....... 3/8/2012
mL).
Cerilliant Corporation................. Drug Solution 15..... Screw-cap Vial: 50 mL.... 6/5/2012
Cerilliant Corporation................. Lacosamide (1 mg/mL)........... Glass Ampule: 2 mL....... 5/31/2012
Cerilliant Corporation................. Lacosamide-13C, D3 (0.1 mg/mL). Glass Ampule: 2 mL....... 12/22/2011
Cerilliant Corporation................. Lacosamide-13C, D3 (1 mg/mL)... Glass Ampule: 1 mL....... 7/31/2012
Cerilliant Corporation................. Lisdexamfetamine dimesylate (1 Glass Ampule: 2 mL....... 12/22/2011
mg/mL).
Cerilliant Corporation................. Lisdexamfetamine-D4 dimesylate Glass Ampule: 2 mL....... 12/22/2011
(0.1 mg/mL).
Cerilliant Corporation................. Mephedrone HCl (1 mg/mL)....... Glass Ampule: 2 mL....... 12/22/2011
Cerilliant Corporation................. Mephedrone-D3 HCl (0.1 mg/mL).. Glass Ampule: 2 mL....... 12/22/2011
Cerilliant Corporation................. Methylone HCl (1 mg/mL)........ Glass Ampule: 2 mL....... 12/22/2011
Cerilliant Corporation................. Methylone-D3 HCl (0.1 mg/mL)... Glass Ampule: 2 mL....... 12/22/2011
Cerilliant Corporation................. Morphine (8 [mu]g/mL).......... Glass Ampule: 2 mL....... 12/22/2011
Cerilliant Corporation................. Naloxone N-oxide (0.1 mg/mL)... Glass Ampule: 2 mL....... 6/5/2012
Cerilliant Corporation................. Norcodeine-D3 (1 mg/mL)........ Glass Ampule: 1 mL....... 7/31/2012
Cerilliant Corporation................. Normeperidine-D4 (1 mg/mL)..... Glass Ampule: 1 mL....... 7/31/2012
Cerilliant Corporation................. Noroxycodone and Norhydrocodone Glass Ampule: 2 mL....... 12/22/2011
Mix (0.5 mg/mL).
Cerilliant Corporation................. Opiate Internal Standard Mix-15 Glass Ampule: 2 mL....... 12/22/2011
[[Page 4452]]
Cerilliant Corporation................. Pseudobuprenorphine Glass Ampule: 1 mL....... 2/1/2012
dihydrochloride (1.0mg/mL).
Cerilliant Corporation................. Pyrovalerone HCl (1 mg/mL)..... Glass Ampule: 2 mL....... 12/22/2011
Cerilliant Corporation................. Secobarbital-D5 (1 mg/mL)...... Glass Ampule: 1 mL....... 7/31/2012
Cerilliant Corporation................. Zolpidem-D7 (0.1 mg/mL)........ Glass Ampule: 2 mL....... 12/22/2011
ElSohly Laboratories, Inc.............. ELI Drug Standards [Delta]9- Glass vial: 1 ml......... 5/31/2012
Tetrahydrocannabinol-
glucoronide (10 [mu]g/mL in
MeOH).
ElSohly Laboratories, Inc.............. ELI Drug Standards [Delta]9- Glass vial: 1 ml......... 5/31/2012
Tetrahydrocannabinol-
glucoronide (100 [mu]g/mL in
MeOH).
Environmental Resource Associates (ERA) Chloral Hydrate, Proficiency Glass Ampule: 2 mL....... 3/8/2012
Testing Material, Catalog No.
853.
Environmental Resource Associates (ERA) Chloral Hydrate, Reference Glass Ampule: 2 mL....... 3/8/2012
Material, Catalog No. 676.
Environmental Resource Associates (ERA) Waters Steroid Test Mix, Part Glass Ampule: 2 mL....... 3/8/2012
No. 07364.
Immunalysis Corporation................ Methadone Calibrator Levels 1-4 Glass vial: 10 mL........ 6/19/2012
Immunalysis Corporation................ Methadone High Control......... Glass vial: 10 mL........ 6/19/2012
Immunalysis Corporation................ Methadone Low Control.......... Glass vial: 10 mL........ 6/19/2012
Immunalysis Corporation................ Oral Fluid Cutoff Calibrator Glass vial: 10 mL........ 6/19/2012
Pain Management Prediluted in
Extraction Buffer.
Immunalysis Corporation................ Oral Fluid High Positive Glass vial: 10 mL........ 6/19/2012
Control Pain Management
Prediluted in Extration Buffer.
Immunalysis Corporation................ Oral Fluid Low Positive Control Glass vial: 10 mL........ 6/19/2012
Pain Management Prediluted in
Extraction Buffer.
Immunalysis Corporation................ Zolpidem Calibrator............ Glass vial: 10 mL........ 6/19/2012
Immunalysis Corporation................ Zolpidem High Control.......... Glass vial: 10 mL........ 6/19/2012
Immunalysis Corporation................ Zolpidem Low Control........... Glass vial: 10 mL........ 6/19/2012
Insys Therapeutics, Inc................ (-)-delta9-Tetrahydrocannabinol Glass Ampule: 1 mL....... 5/9/2012
(1.0 mg/mL).
Microgenics Corporation................ CEDIA Amphetamine OFT Assay, Box: 4 bottles; 65 mL 12/22/2011
Catalog Number: 10014947. each.
Microgenics Corporation................ CEDIA Cannabinoids OFT Assay, Box: 4 bottles; 65 mL 12/22/2011
Catalog Number: 10014910. each.
Microgenics Corporation................ CEDIA Cocaine OFT Assay, Box: 4 bottles; 65 mL 12/22/2011
Catalog Number: 10014764. each.
Microgenics Corporation................ CEDIA Methamphetamine OFT Box: 4 bottles; 65 mL 12/22/2011
Assay, Catalog Number: each.
10014949.
Microgenics Corporation................ CEDIA Methamphetamine OFT Vial: 10 mL Box: 2 vials. 12/22/2011
Control Set (Low and High) ,
Catalog 10014953.
Microgenics Corporation................ CEDIA Methamphetamine OFT Vial: 5 mL Box: 1 vial... 12/22/2011
Cutoff Calibrator, Catalog
10014951.
Microgenics Corporation................ CEDIA Methamphetamine OFT High Vial: 5 mL Box: 1 vial... 12/22/2011
Calibrator, Catalog 10014952.
Microgenics Corporation................ CEDIA Multi-Drug OFT Control Vial: 15 mL Box: 2 vials. 12/22/2011
Set (Low and High), Catalog
10014957.
Microgenics Corporation................ CEDIA Multi-Drug OFT Cutoff Vial: 10 mL Box: 1 vial.. 12/22/2011
Calibrator, Catalog 10014955.
Microgenics Corporation................ CEDIA Multi-Drug OFT High Vial: 10 mL Box: 1 vial.. 12/22/2011
Calibrator, Catalog 10014956.
Microgenics Corporation................ CEDIA Opiate OFT Assay, Catalog Box: 4 bottles; 65 mL 12/22/2011
Number: 10014873. each.
Microgenics Corporation................ CEDIA PCP OFT Assay, Catalog Box: 4 bottles; 65 mL 12/22/2011
Number: 10014888. each.
Microgenics Corporation................ CEDIA THC OFT Control Set (Low Vial: 10 mL Box: 2 vials. 12/22/2011
and High), Catalog 10014925.
Microgenics Corporation................ CEDIA THC OFT Cutoff Vial: 5 mL Box: 1 vial... 12/22/2011
Calibrator, Catalog 10014923.
Microgenics Corporation................ CEDIA THC OFT High Calibrator, Vial: 5 mL Box: 1 vial... 12/22/2011
Catalog 10014924.
Microgenics Corporation................ Thermo Scientific CEDIA Vial: 5 mL Box: 1 vial... 7/5/2012
Methamphetamine OFT Calibrator
1, Catalog Number: 10016345.
Microgenics Corporation................ Thermo Scientific CEDIA Vial: 5 mL Box: 1 vial... 7/5/2012
Methamphetamine OFT Calibrator
1, Catalog Number: 10016362.
Microgenics Corporation................ Thermo Scientific CEDIA Vial: 5 mL Box: 1 vial... 7/5/2012
Methamphetamine OFT Calibrator
2, Catalog Number: 10016346.
Microgenics Corporation................ Thermo Scientific CEDIA Vial: 5 mL Box: 1 vial... 7/5/2012
Methamphetamine OFT Calibrator
2, Catalog Number: 10016363.
Microgenics Corporation................ Thermo Scientific CEDIA Vial: 5 mL Box: 1 vial... 7/5/2012
Methamphetamine OFT Calibrator
3, Catalog Number: 10016347.
Microgenics Corporation................ Thermo Scientific CEDIA Vial: 5 mL Box: 1 vial... 7/5/2012
Methamphetamine OFT Calibrator
3, Catalog Number: 10016364.
Microgenics Corporation................ Thermo Scientific CEDIA Vial: 5 mL Box: 1 vial... 7/5/2012
Methamphetamine OFT Calibrator
4, Catalog Number: 10016348.
[[Page 4453]]
Microgenics Corporation................ Thermo Scientific CEDIA Vial: 10 mL Box: 2 vials. 7/5/2012
Methamphetamine OFT Control
Set (Low and High), Catalog
Number: 10016349.
Microgenics Corporation................ Thermo Scientific CEDIA Vial: 10 mL Box: 2 vials. 7/5/2012
Methamphetamine OFT Control
Set (Low and High), Catalog
Number: 10016365.
Microgenics Corporation................ Thermo Scientific CEDIA Vial: 10 mL Box: 2 vials. 7/5/2012
Methamphetamine OFT Control
Set (Low and High), Catalog
Number: 10016808.
Microgenics Corporation................ Thermo Scientific CEDIA Vial: 5 mL Box: 1 vial... 7/5/2012
Methamphetamine OFT Cutoff
Calibrator, Catalog Number:
10016807.
Microgenics Corporation................ Thermo Scientific CEDIA Multi- Vial: 10 mL Box: 1 vial.. 7/5/2012
Drug OFT Calibrator 1, Catalog
Number: 10016865.
Microgenics Corporation................ Thermo Scientific CEDIA Multi- Vial: 10 mL Box: 1 vial.. 7/5/2012
Drug OFT Calibrator 1, Catalog
Number: 10016882.
Microgenics Corporation................ Thermo Scientific CEDIA Multi- Vial: 10 mL Box: 1 vial.. 7/5/2012
Drug OFT Calibrator 2, Catalog
Number: 10016866.
Microgenics Corporation................ Thermo Scientific CEDIA Multi- Vial: 10 mL Box: 1 vial.. 7/5/2012
Drug OFT Calibrator 2, Catalog
Number: 10016883.
Microgenics Corporation................ Thermo Scientific CEDIA Multi- Vial: 10 mL Box: 1 vial.. 7/5/2012
Drug OFT Calibrator 3, Catalog
Number: 10016867.
Microgenics Corporation................ Thermo Scientific CEDIA Multi- Vial: 10 mL Box: 1 vial.. 7/5/2012
Drug OFT Calibrator 3, Catalog
Number: 10016884.
Microgenics Corporation................ Thermo Scientific CEDIA Multi- Vial: 10 mL Box: 1 vial.. 7/5/2012
Drug OFT Calibrator 4, Catalog
Number: 10016868.
Microgenics Corporation................ Thermo Scientific CEDIA Multi- Vial: 15 mL Box: 2 vials. 7/5/2012
Drug OFT Control Set (Low and
High), Catalog Number:
10016869.
Microgenics Corporation................ Thermo Scientific CEDIA Multi- Vial: 15 mL Box: 2 vials. 7/5/2012
Drug OFT Control Set (Low and
High), Catalog Number:
10016885.
Microgenics Corporation................ Thermo Scientific CEDIA Multi- Vial: 15 mL Box: 2 vials. 7/5/2012
Drug OFT Control Set (Low and
High), Catalog Number:
10016895.
Microgenics Corporation................ Thermo Scientific CEDIA Multi- Vial: 10 mL Box: 1 vial.. 7/5/2012
Drug OFT Cutoff Calibrator,
Catalog Number: 10016894.
Microgenics Corporation................ Thermo Scientific CEDIA THC OFT Vial: 5 mL Box: 1 vial... 7/5/2012
Calibrator 1 Catalog Number:
10016644.
Microgenics Corporation................ Thermo Scientific CEDIA THC OFT Vial: 5 mL Box: 1 vial... 7/5/2012
Calibrator 1 Catalog Number:
10016700.
Microgenics Corporation................ Thermo Scientific CEDIA THC OFT Vial: 5 mL Box: 1 vial... 7/5/2012
Calibrator 2 Catalog Number:
10016646.
Microgenics Corporation................ Thermo Scientific CEDIA THC OFT Vial: 5 mL Box: 1 vial... 7/5/2012
Calibrator 2 Catalog Number:
10016701.
Microgenics Corporation................ Thermo Scientific CEDIA THC OFT Vial: 5 mL Box: 1 vial... 7/5/2012
Calibrator 3 Catalog Number:
10016647.
Microgenics Corporation................ Thermo Scientific CEDIA THC OFT Vial: 5 mL Box: 1 vial... 7/5/2012
Calibrator 3 Catalog Number:
10016702.
Microgenics Corporation................ Thermo Scientific CEDIA THC OFT Vial: 5 mL Box: 1 vial... 7/5/2012
Calibrator 4 Catalog Number:
10016648.
Microgenics Corporation................ Thermo Scientific CEDIA THC OFT Vial: 10 mL Box: 2 vials. 7/5/2012
Control Set (Low and High),
Catalog Number: 10016649.
Microgenics Corporation................ Thermo Scientific CEDIA THC OFT Vial: 10 mL Box: 2 vials. 7/5/2012
Control Set (Low and High),
Catalog Number: 10016703.
Microgenics Corporation................ Thermo Scientific CEDIA THC OFT Vial: 10 mL Box: 2 vials. 7/5/2012
Control Set (Low and High),
Catalog Number: 10016731.
Microgenics Corporation................ Thermo Scientific CEDIA THC OFT Vial: 5 mL Box: 1 vial... 7/5/2012
Cutoff Calibrator Catalog
Number: 10016730.
Microgenics Corporation................ Thermo Scientific DRI Fentanyl Vials: 500 mL............ 5/31/2012
Assay Catalog Number: 10016005.
Microgenics Corporation................ Thermo Scientific DRI Fentanyl 3 vials, 18 mL each...... 5/31/2012
Assay Catalog Number: 10016006.
Microgenics Corporation................ Thermo Scientific DRI Fentanyl 3 vials, 18 mL each...... 5/31/2012
Assay Catalog Number: 10016437.
Microgenics Corporation................ Thermo Scientific DRI Fentanyl Vials: 10 mL............. 5/31/2012
Calibrator 2 ng/mL Catalog
Number: 10016023.
Microgenics Corporation................ Thermo Scientific DRI Fentanyl Box: 1 vial; 25 mL....... 5/31/2012
High Control 1 ng/mL Catalog
Number: 10016484.
Microgenics Corporation................ Thermo Scientific DRI Fentanyl Box: 1 vial; 10 mL....... 5/31/2012
High Control 2 ng/mL Catalog
Number: 10016485.
[[Page 4454]]
Microgenics Corporation................ Thermo Scientific DRI Fentanyl Vials: 25 mL............. 5/31/2012
High Control 3 ng/mL Catalog
Number: 10016024.
Microgenics Corporation................ Thermo Scientific DRI Fentanyl Box: 1 vial; 25 mL....... 5/31/2012
High Control 3 ng/mL Catalog
Number: 10016486.
Microgenics Corporation................ Thermo Scientific DRI Fentanyl Vials: 25 mL............. 5/31/2012
Low Control 1 ng/mL Catalog
Number: 10016022.
Microgenics Corporation................ Thermo Scientific MAS Vial 5 mL; Box: 6 vials.. 12/22/2011
OmniCORE Liquid
Assayed Integrated Chemistry
Control Levels 1-3.
Microgenics Corporation................ Thermo Scientific MAS Box: 6 vials; 5 mL each.. 12/22/2011
OmniCORE Liquid
Assayed Integrated Chemistry
Control Sample Pack.
Microgenics Corporation................ Thermo Scientific MAS Vial 5 mL; Box: 6 vials.. 12/22/2011
OmniIMMUNE Liquid
Assayed Integrated Chemistry
Control Levels 1-3.
Microgenics Corporation................ Thermo Scientific MAS Box: 6 vials; 5 mL each.. 12/22/2011
OmniIMMUNE Liquid
Assayed Integrated Chemistry
Control Sample Pack.
Microgenics Corporation................ Thermo Scientific MAS Vial 5 mL; Box: 6 vials.. 12/22/2011
OmniIMMUNE PRO Liquid
Assayed Integrated Chemistry
Control Levels 1-3.
Microgenics Corporation................ Thermo Scientific MAS Box: 6 vials; 5 mL each.. 12/22/2011
OmniIMMUNE PRO Liquid
Assayed Integrated Chemistry
Control Sample Pack.
Restek Corporation..................... Appendix IX Mix 1, Ampule: 2 mL............. 12/22/2011
Revised.
Restek Corporation..................... Custom a,a- Ampule: 2 mL............. 12/22/2011
Dimethylphenethylamine
Standard.
Restek Corporation..................... Custom Chloral Hydrate Standard Ampule: 2 mL............. 12/22/2011
Restek Corporation..................... Custom LS4434 Standard 1....... Ampule: 2 mL............. 7/5/2012
Restek Corporation..................... Metabolomic Standard Mix 1.
Restek Corporation..................... UCMR3 Method 539 Calibration Ampule: 2 mL............. 12/22/2011
Standard.
Restek Corporation..................... UCMR3 Method Calibration Ampule: 2 mL............. 5/31/2012
Standard.
Roche Diagnostics Operations, Inc...... Oral Fluid DAT Cal A Levels 1-5 Glass vial: 5 mL......... 7/31/2012
Roche Diagnostics Operations, Inc...... Oral Fluid DAT Cal B Levels 1-5 Glass vial: 5 mL......... 7/31/2012
Roche Diagnostics Operations, Inc...... Oral Fluid DAT Control Set A Box of 6 vials, 10 mL 7/31/2012
Material No. 05473390190. each.
Roche Diagnostics Operations, Inc...... Oral Fluid DAT Control Set B Box of 6 vials, 10 mL 7/31/2012
Material No. 05473411190. each.
Roche Diagnostics Operations, Inc...... Oral Fluid DAT Qual Cal Box of 4 vials, 5 mL each 7/31/2012
Material No. 05475929190.
Roche Diagnostics Operations, Inc...... Oral Fluid DAT SQ Cal A Box of 6 vials, 5 mL each 7/31/2012
Material No. 05475872190.
Roche Diagnostics Operations, Inc...... Oral Fluid DAT SQ Cal B Box of 6 vials, 5 mL each 7/31/2012
Material No. 05475899190.
SAFC Biosciences....................... HH-4 Cell Culture Medium....... Bag: 1L, 200L, 500L; 2/3/2012
Bottle: 1L, 2L.
SAFC Biosciences....................... HH-4 Cell Culture Medium....... Bag: 20 L, 100L, 1,000 L. 3/22/2012
Siemens Healthcare Diagnostics Inc..... ADVIA Chemistry Drug CAL 1..... Carton: 10 vials; 3 ml 11/5/2012
each.
Siemens Healthcare Diagnostics Inc..... ADVIA Chemistry Drug CAL 1, Vial: 3 mL............... 11/5/2012
Level 2.
Siemens Healthcare Diagnostics Inc..... ADVIA Chemistry Drug CAL 1, Vial: 3 mL............... 11/5/2012
Level 3.
Siemens Healthcare Diagnostics Inc..... ADVIA Chemistry Drug CAL 1, Vial: 3 mL............... 11/5/2012
Level 4.
Siemens Healthcare Diagnostics Inc..... ADVIA Chemistry Drug CAL 1, Vial: 3 mL............... 11/5/2012
Level 5.
Siemens Healthcare Diagnostics Inc..... Bulk EII Plus THC CAL 2 ML..... Bulk Container: 4 mL-100 12/22/2011
L.
Siemens Healthcare Diagnostics Inc..... Bulk EII Plus THC CAL 3 ML..... Bulk Container: 4 mL-100 12/22/2011
L.
Siemens Healthcare Diagnostics Inc..... Bulk EII Plus THC CAL 4 ML..... Bulk Container: 4 mL-100 12/22/2011
L.
Siemens Healthcare Diagnostics Inc..... Bulk EII Plus THC CAL 5 ML..... Bulk Container: 4 mL-100 12/22/2011
L.
Siemens Healthcare Diagnostics Inc..... Bulk EII Plus THC Control 1 ML. Bulk Container: 4 mL-100 12/22/2011
L.
Siemens Healthcare Diagnostics Inc..... Bulk EII Plus THC Control 2 ML. Bulk Container: 4 mL-100 12/22/2011
L.
Siemens Healthcare Diagnostics Inc..... Bulk EII Plus THC Control 3 ML. Bulk Container: 4 mL-100 12/22/2011
L.
Siemens Healthcare Diagnostics Inc..... Bulk EII Plus THC Control 4 ML. Bulk Container: 4 mL-100 12/22/2011
L.
Siemens Healthcare Diagnostics Inc..... Bulk EII Plus THC Control 5 ML. Bulk Container: 4 mL-100 12/22/2011
L.
Siemens Healthcare Diagnostics Inc..... Bulk EII Plus THC Control 6 ML. Bulk Container: 4 mL-100 12/22/2011
L.
Siemens Healthcare Diagnostics Inc..... Dimension Drug Calibrator, Vial: 2.5 mL............. 11/5/2012
Level 2.
Siemens Healthcare Diagnostics Inc..... Dimension Drug Calibrator, Vial: 2.5 mL............. 11/5/2012
Level 3.
Siemens Healthcare Diagnostics Inc..... Dimension Drug Calibrator, Vial: 2.5 mL............. 11/5/2012
Level 4.
Siemens Healthcare Diagnostics Inc..... Dimension Drug Calibrator, Vial: 2.5 mL............. 11/5/2012
Level 5.
Siemens Healthcare Diagnostics Inc..... Dimension Clinical Chemistry Carton: 10 vials; 2.5 ml 11/5/2012
System DRUG Calibrator. each.
Siemens Healthcare Diagnostics Inc..... Dimension Vista DRUG 1 CAL, B.. Vial: 2.5 mL............. 7/31/2012
Siemens Healthcare Diagnostics Inc..... Dimension Vista Drug 4 CAL, Vial: 3 mL............... 11/5/2012
Level B.
Siemens Healthcare Diagnostics Inc..... Dimension Vista Drug 4 CAL, Vial: 3 mL............... 11/5/2012
Level C.
Siemens Healthcare Diagnostics Inc..... Dimension Vista Drug 4 CAL, Vial: 3 mL............... 11/5/2012
Level D.
Siemens Healthcare Diagnostics Inc..... Dimension Vista Drug 4 CAL, Vial: 3 mL............... 11/5/2012
Level E.
Siemens Healthcare Diagnostics Inc..... Dimension Vista LOCI 8 CAL..... Box of 10 vials; Vial: 3/22/2012
2.5 mL.
Siemens Healthcare Diagnostics Inc..... Dimension Vista LOCI 9 CAL Vial: 1.5 mL............. 12/22/2011
Levels A-E.
[[Page 4455]]
Siemens Healthcare Diagnostics Inc..... Dimension Vista System DRUG 1 Carton: 6 vials; 2.5 mL 7/31/2012
CAL. each.
Siemens Healthcare Diagnostics Inc..... Dimension Vista System Drug 4 Carton: 10 vials; 3 ml 11/5/2012
CAL. each.
Siemens Healthcare Diagnostics Inc..... Dimension Vista System LOCI 9 Box of 10 vials; Vial: 12/22/2011
Calibrator. 1.5 mL.
Siemens Healthcare Diagnostics Inc..... Dimension Vista UDAT CAL....... Glass vial: 3 mL; Carton: 12/22/2011
6 vials.
Siemens Healthcare Diagnostics Inc..... Dimension Vista UDAT CAL Bulk, Bulk Container: 20 L-25 L 5/31/2012
Level B.
Siemens Healthcare Diagnostics Inc..... Dimension Vista UDAT CAL Pilot, Pilot Container: 2 mL-125 5/31/2012
Level B. mL.
Siemens Healthcare Diagnostics Inc..... Dimension Vista UDAT CAL, Level Glass vial: 3 mL......... 12/22/2011
B.
Siemens Healthcare Diagnostics Inc..... FC EII Plus THC CAL 2 ML....... Plastic vial: 15 mL...... 12/22/2011
Siemens Healthcare Diagnostics Inc..... FC EII Plus THC CAL 3 ML....... Plastic vial: 15 mL...... 12/22/2011
Siemens Healthcare Diagnostics Inc..... FC EII Plus THC CAL 4 ML....... Plastic vial: 15 mL...... 12/22/2011
Siemens Healthcare Diagnostics Inc..... FC EII Plus THC CAL 5 ML....... Plastic vial: 15 mL...... 12/22/2011
Siemens Healthcare Diagnostics Inc..... FC EII Plus THC Control 1 ML... Plastic vial: 15 mL...... 12/22/2011
Siemens Healthcare Diagnostics Inc..... FC EII Plus THC Control 2 ML... Plastic vial: 15 mL...... 12/22/2011
Siemens Healthcare Diagnostics Inc..... FC EII Plus THC Control 3 ML... Plastic vial: 15 mL...... 12/22/2011
Siemens Healthcare Diagnostics Inc..... FC EII Plus THC Control 4 ML... Plastic vial: 15 mL...... 12/22/2011
Siemens Healthcare Diagnostics Inc..... FC EII Plus THC Control 5 ML... Plastic vial: 15 mL...... 12/22/2011
Siemens Healthcare Diagnostics Inc..... FC EII Plus THC Control 6 ML... Plastic vial: 15 mL...... 12/22/2011
Siemens Healthcare Diagnostics Inc..... MP LOCI 9 TTST Cal Lvl 1-7 FC.. Vial: 1-5 mL............. 12/22/2011
Siemens Healthcare Diagnostics Inc..... MP LOCI 9 TTST Lvl 1-7 Bulk.... Bulk container: 4 mL-100 12/22/2011
L.
Siemens Healthcare Diagnostics Inc..... VS Drug 1 Cal Bulk Soln, Level Bulk container: 2 mL-1 L. 7/31/2012
B.
Siemens Healthcare Diagnostics Inc..... VS LOCI 9 CAL BULK SOLN Levels Bulk container: 4 mL-100 12/22/2011
1-5. L.
Siemens Healthcare Diagnostics Inc..... VS LOCI CAL 8 BULK SOLN Level 2 Bulk container: 4 mL-100 3/22/2012
L.
Siemens Healthcare Diagnostics Inc..... VS LOCI CAL 8 BULK SOLN Level 3 Bulk container: 4 mL-100 3/22/2012
L.
Siemens Healthcare Diagnostics Inc..... VS LOCI CAL 8 BULK SOLN Level 4 Bulk container: 4 mL-100 3/22/2012
L.
Siemens Healthcare Diagnostics Inc..... VS LOCI CAL 8 BULK SOLN Level 5 Bulk container: 4 mL-100 3/22/2012
L.
Siemens Healthcare Diagnostics Inc..... VS LOCI CAL 8 Vial Level E..... Vial: 2.5 mL............. 3/22/2012
Siemens Healthcare Diagnostics Inc..... VS LOCI CAL 8 Vial Level B..... Vial: 2.5 mL............. 3/22/2012
Siemens Healthcare Diagnostics Inc..... VS LOCI CAL 8 Vial Level C..... Vial: 2.5 mL............. 3/22/2012
Siemens Healthcare Diagnostics Inc..... VS LOCI CAL 8 Vial Level D..... Vial: 2.5 mL............. 3/22/2012
Supelco, Inc........................... Custom Mix, 0.2-163.2 [mu]g/mL Glass ampule: 1 mL....... 7/31/2012
in methanol.
Ultra Scientific, Inc.................. DSA Detection Cocaine HCl Amber ampule: 1 mL....... 12/22/2011
Standard.
Ultra Scientific, Inc.................. DSA Detection Cocaine HCl Amber ampule: 1 mL....... 12/22/2011
StandardPhenobarbital (625
[mu]g/mL).
Ultra Scientific, Inc.................. DSA Detection Cocaine HCl Amber ampule: 1 mL....... 12/22/2011
StandardPhenobarbital (6400
[mu]g/mL).
Ultra Scientific, Inc.................. GE-Ion Track 100 ng/[mu]L TNT/ Amber ampule: 10 mL...... 12/22/2011
Cocaine HCl Standard Rev. 1.
Ultra Scientific, Inc.................. GE-Ion Track 100 ng/[mu]L TNT/ Glass bottle: 100 mL..... 12/22/2011
Cocaine HCl Standard Rev. 1.
Ultra Scientific, Inc.................. Phenobarbital (625 [mu]g/mL)... Amber ampule: 1 mL....... 5/31/2012
Ultra Scientific, Inc.................. Phenobarbital (6400 [mu]g/mL).. Amber ampule: 1 mL....... 5/31/2012
Ultra Scientific, Inc.................. Ultracheck WS Chloral Hydrate Glass ampule: 2 mL....... 12/22/2011
Sample.
----------------------------------------------------------------------------------------------------------------
The Deputy Assistant Administrator has found that each of the
compounds, mixtures, and preparations described in Chart II below is
not consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and
in 21 CFR 1308.23. Accordingly, the Deputy Assistant Administrator has
determined that the chemical preparations or mixtures generally
described in Chart II below and specifically described in the
application materials received by DEA, are not exempt from application
of the CSA or from application of the CFR, with regard to the requested
exemption pursuant to 21 CFR 1308.23, as of the date listed below that
was provided in the determination letters to the individual requesters.
Chart II
----------------------------------------------------------------------------------------------------------------
Supplier Product name Form Denial date
----------------------------------------------------------------------------------------------------------------
Abbott Laboratories.................... ARCHITECT Estradiol Assay Tank: 50-500 L........... 12/22/2011
Diluent, No. 2K25J.
Abbott Laboratories.................... AxSYM Estradiol Buffer......... Bulk Tank: 50-500 L; Bag- 12/22/2011
in-box: 18-200 L.
American Radiolabeled Chemicals, Inc... Lysergic acid diethylamide..... Vial: 1 mL............... 12/22/2011
Biochemical Diagnostics, Inc........... Benzoylecgonine Bulk Solution Bottle: 1 ml-1 L......... 11/15/2011
(5 mg/mL).
Biochemical Diagnostics, Inc........... Cocaine Bulk Solution(5 mg/mL). Bottle: 1 ml-1 L......... 11/15/2011
Biochemical Diagnostics, Inc........... Codeine Bulk Solution(5 mg/mL). Bottle: 1 ml-1 L......... 11/15/2011
Biochemical Diagnostics, Inc........... d-Amphetamine Bulk Solution (5 Bottle: 1 ml-1 L......... 11/15/2011
mg/mL).
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 500 ml-2 L.. 11/15/2011
Control Urine, MC134.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 500 ml-2 L.. 11/15/2011
Control Urine, MC135.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 200 ml-2 L.. 11/15/2011
Control Urine, MC136.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 500 ml-2 L.. 11/15/2011
Control Urine, MC137.
[[Page 4456]]
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 500 ml-2 L.. 11/15/2011
Control Urine, MC138.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 500 ml-2 L.. 11/15/2011
Control Urine, MC139.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 500 ml-2 L.. 11/15/2011
Control Urine, MC140.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 500 ml-2 L.. 11/15/2011
Control Urine, MC141.
Biochemical Diagnostics, Inc........... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL. 11/15/2011
Control Urine, MC142.
Biochemical Diagnostics, Inc........... d-Methamphetamine Bulk Bottle: 1 ml-1 L......... 11/15/2011
Solution(5 mg/mL).
Biochemical Diagnostics, Inc........... d-Propoxyphene Bulk Solution (5 Bottle: 1 ml-1 L......... 11/15/2011
mg/mL).
Biochemical Diagnostics, Inc........... Hydrocodone Bulk Solution(5 mg/ Bottle: 1 ml-1 L......... 11/15/2011
mL).
Biochemical Diagnostics, Inc........... Hydromorphone Bulk Solution(5 Bottle: 1 ml-1 L......... 11/15/2011
mg/mL).
Biochemical Diagnostics, Inc........... MDA Bulk Solution(5 mg/mL)..... Bottle: 1 ml-1 L......... 11/15/2011
Biochemical Diagnostics, Inc........... MDEA Bulk Solution(5 mg/mL).... Bottle: 1 ml-1 L......... 11/15/2011
Biochemical Diagnostics, Inc........... MDMA Bulk Solution(5 mg/mL).... Bottle: 1 ml-1 L......... 11/15/2011
Biochemical Diagnostics, Inc........... Methadone Bulk Solution(5 mg/ Bottle: 1 ml-1 L......... 11/15/2011
mL).
Biochemical Diagnostics, Inc........... Methaqualone Bulk Solution(5 mg/ Bottle: 1 ml-1 L......... 11/15/2011
mL).
Biochemical Diagnostics, Inc........... Morphine Bulk Solution (5 mg/ Bottle: 1 ml-1 L......... 11/15/2011
mL).
Biochemical Diagnostics, Inc........... Oxazepam Bulk Solution (5 mg/ Bottle: 1 ml-1 L......... 11/15/2011
mL).
Biochemical Diagnostics, Inc........... Secobarbital Bulk Solution (5 Bottle: 1 ml-1 L......... 11/15/2011
mg/mL).
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 20mL......... 12/22/2011
Control C1 Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 20mL......... 12/22/2011
Control C2 Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 20mL......... 12/22/2011
Control C3 Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 20mL......... 12/22/2011
Control C4 Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 20mL......... 12/22/2011
Control Low Opiate Level C2
Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 20mL......... 12/22/2011
Control Low Opiate Level C3
Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 10mL......... 12/22/2011
Control S1 Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 10mL......... 12/22/2011
Control S1E Low Opiate Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 10mL......... 12/22/2011
Control S1E Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 10mL......... 12/22/2011
Control S1S Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 10mL......... 12/22/2011
Control S2 Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 10mL......... 12/22/2011
Control S2E Low Opiate Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 10mL......... 12/22/2011
Control S2E Minipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 10mL......... 12/22/2011
Control S2SMinipak.
Bio-Rad Laboratories................... Liquichek Urine Toxicology Amber Vial: 10mL......... 12/22/2011
Control S3 Minipak.
Cayman Chemical Company................ 4-Methylmethcathinone Glass vial: 1 mL......... 7/31/2012
(hydrochloride), 10 mg in 1 mL
Methanol.
Cayman Chemical Company................ 4-Methylmethcathinone Glass vial: 2.5 mL....... 7/31/2012
(hydrochloride), 25 mg in 2.5
mL Methanol.
Cayman Chemical Company................ 4-Methylmethcathinone Glass vial: 500 [micro]L. 7/31/2012
(hydrochloride), 5 mg in 500
[micro]L Methanol.
Cayman Chemical Company................ 5-methoxy DMT, 10 mg in 1 mL Glass vial: 1 mL......... 7/31/2012
Methanol.
Cayman Chemical Company................ 5-methoxy DMT, 25 mg in 2.5 mL Glass vial: 2.5 mL....... 7/31/2012
Methanol.
Cayman Chemical Company................ 5-methoxy DMT, 5 mg in 500 Glass vial: 500 [micro]L. 7/31/2012
[micro]L Methanol.
Cayman Chemical Company................ Methylenedioxy Pyrovalerone Glass vial: 1 mL......... 7/31/2012
(hydrochloride), 10 mg in 1 mL
Methanol.
Cayman Chemical Company................ Methylenedioxy Pyrovalerone Glass vial: 2.5 mL....... 7/31/2012
(hydrochloride), 25 mg in 2.5
mL Methanol.
Cayman Chemical Company................ Methylenedioxy Pyrovalerone Glass vial: 500 [micro]L. 7/31/2012
(hydrochloride), 5 mg in 500
[micro]L Methanol.
Cayman Chemical Company................ Methylenedioxy Pyrovalerone, 10 Glass vial: 1 mL......... 7/31/2012
mg in 1 mL Methanol.
Cayman Chemical Company................ Methylenedioxy Pyrovalerone, 25 Glass vial: 2.5 mL....... 7/31/2012
mg in 2.5 mL Methanol.
Cayman Chemical Company................ Methylenedioxy Pyrovalerone, 5 Glass vial: 500 [micro]L. 7/31/2012
mg in 500 [micro]L Methanol.
Cayman Chemical Company................ Methylenedioxy Pyrovalerone-d8 Glass vial: 1 mL......... 7/31/2012
(hydrochloride), 10 mg in 1 mL
Methanol.
Cayman Chemical Company................ Methylenedioxy Pyrovalerone-d8 Glass vial: 2.5 mL....... 7/31/2012
(hydrochloride), 25 mg in 2.5
mL Methanol.
Cayman Chemical Company................ Methylenedioxy Pyrovalerone-d8 Glass vial: 500 [micro]L. 7/31/2012
(hydrochloride), 5 mg in 500
[micro]L Methanol.
Cayman Chemical Company................ Methylone (hydrochloride), 10 Glass vial: 1 mL......... 7/31/2012
mg in 1 mL Methanol.
Cayman Chemical Company................ Methylone (hydrochloride), 25 Glass vial: 2.5 mL....... 7/31/2012
mg in 2.5 mL Methanol.
Cayman Chemical Company................ Methylone (hydrochloride), 5 mg Glass vial: 500 [micro]L. 7/31/2012
in 500 [micro]L Methanol.
Cerilliant Corporation................. Codeine (1 mg/mL).............. Glass ampule: 5 mL....... 7/31/2012
Cerilliant Corporation................. Codeine-D3 (1 mg/mL)........... Glass ampule: 5 mL....... 7/31/2012
Cerilliant Corporation................. Drug Solution 16..... Screw-cap Vial: 50 mL.... 6/5/2012
[[Page 4457]]
Cerilliant Corporation................. Drug Solution 17..... Screw-cap Vial: 50 mL.... 6/5/2012
Cerilliant Corporation................. Drug Solution 18..... Screw-cap Vial: 50 mL.... 6/5/2012
Cerilliant Corporation................. Drug Solution 19..... Screw-cap Vial: 50 mL.... 6/5/2012
Cerilliant Corporation................. Drug Solution 20..... Screw-cap Vial: 50 mL.... 6/5/2012
Cerilliant Corporation................. Hydrocodone (1 mg/mL).......... Glass ampule: 5 mL....... 7/31/2012
Cerilliant Corporation................. Hydrocodone-D6 (1 mg/mL)....... Glass ampule: 5 mL....... 7/31/2012
Cerilliant Corporation................. Hydromorphone (1 mg/mL)........ Glass ampule: 5 mL....... 7/31/2012
Cerilliant Corporation................. Hydromorphone-D3 (1 mg/mL)..... Glass ampule: 5 mL....... 7/31/2012
Cerilliant Corporation................. Morphine (1 mg/mL)............. Glass ampule: 5 mL....... 7/31/2012
Cerilliant Corporation................. Morphine-D3 (1 mg/mL).......... Glass ampule: 5 mL....... 7/31/2012
Cerilliant Corporation................. Noroxycodone HCl (1 mg/mL)..... Glass ampule: 5 mL....... 7/31/2012
Cerilliant Corporation................. Noroxycodone-D3 HCl (1 mg/mL).. Glass ampule: 5 mL....... 7/31/2012
Cerilliant Corporation................. Oxycodone (1 mg/mL)............ Glass ampule: 5 mL....... 7/31/2012
Cerilliant Corporation................. Oxycodone-D3 (1 mg/mL)......... Glass ampule: 5 mL....... 7/31/2012
Cerilliant Corporation................. Oxymorphone (1 mg/mL).......... Glass ampule: 5 mL....... 7/31/2012
Cerilliant Corporation................. Oxymorphone-D3 (1 mg/mL)....... Glass ampule: 5 mL....... 7/31/2012
Environmental Resource Associates (ERA) USGS BQS LS4434 Mix 1.......... Glass Ampule: 1-2 mL..... 7/31/2012
Environmental Resource Associates (ERA) USGS BQS LS4434 Mix 2.......... Glass Ampule: 1-2 mL..... 7/31/2012
Immunalysis Corporation................ Tapentadol Calibrator Levels 1- Glass vial: 10 mL........ 6/19/2012
4.
Immunalysis Corporation................ Tapentadol High Control........ Glass vial: 10 mL........ 6/19/2012
Immunalysis Corporation................ Tapentadol Low Control......... Glass vial: 10 mL........ 6/19/2012
Restek Corporation..................... Custom Cannabinoids Standard... Ampule: 2 mL............. 5/31/2012
Restek Corporation..................... Custom Paraldehyde Standard (10 Ampule: 2 mL............. 7/5/2012
mg/mL).
Siemens Healthcare Diagnostics Inc..... Dimension Vista UDAT CAL Bulk, Bulk Container: 4mL-100L. 12/22/2011
Level B.
Siemens Healthcare Diagnostics Inc..... Dimension Vista UDAT CAL Bulk, Bulk Container: 26 L-50L. 5/31/2012
Level B.
Siemens Healthcare Diagnostics Inc..... Drug CAL BULK SOLN, Level 2.... Bulk container: 2 L-100 L 11/5/2012
Siemens Healthcare Diagnostics Inc..... Drug CAL BULK SOLN, Level 3.... Bulk container: 2 mL-100 11/5/2012
L.
Siemens Healthcare Diagnostics Inc..... Drug CAL BULK SOLN, Level 4.... Bulk container: 2 mL-100 11/5/2012
L.
Siemens Healthcare Diagnostics Inc..... Drug CAL BULK SOLN, Level 5.... Bulk container: 2m L-100 11/5/2012
L.
Siemens Healthcare Diagnostics Inc..... VS Drug 1 Cal Bulk Soln, Level Bulk container: 2 mL-100 7/31/2012
B. L.
----------------------------------------------------------------------------------------------------------------
Scope of Approval
The exemptions are applicable only to the precise preparation or
mixture described in the application submitted to DEA in the form(s)
listed in this order. Pursuant to 21 CFR 1308.24(h), any change in the
quantitative or qualitative composition of the preparation or mixture
or change in the trade name or other designation of the preparation or
mixture after the date of application requires a new application.
Pursuant to 21 CFR 1308.24(g), DEA may prescribe requirements other
than those set forth in 1308.24(b)-(e) on a case-by-case basis for
materials exempted in bulk quantities. Accordingly, in order to limit
opportunity for diversion from the larger bulk quantities, DEA has
determined that each of the exempted bulk products listed in this order
may only be used in-house and may not be transported to other
facilities.
Additional exempt chemical preparation requests received between
June 12, 2011, and June 30, 2012, and not otherwise referenced in this
order may remain pending until DEA receives additional information
required, pursuant to 21 CFR 1308.23(d), as detailed in separate
correspondence to individual requesters. DEA's order on such requests
will be published in a future Federal Register.
Chemical Preparations Containing Newly Controlled Substances
The statutory authority for exempt chemical preparations is based
on the control status of substances contained within a preparation, the
intended administration of a preparation, and the packaged form of a
preparation. DEA conducts a case-by-case analysis of each application
for exemption to determine whether exemption of a preparation from
certain provisions of the CSA is appropriate pursuant to the specified
statutory and regulatory requirements.
Most exempt chemical preparations have remained effective
indefinitely unless the holder of a specific exempt chemical
preparation specifically requested that the exemption be terminated.
The CSA allows for modifications to the controlled substances schedules
to add, remove, or change the schedule of substances thus resulting in
periodic modifications to the control status of various substances. 21
U.S.C. 811(a). Since the CSA was enacted in 1970, DEA has on several
occasions added to, removed from, or modified the schedules of
controlled substances in accordance with the CSA. Such changes may
result in the non-compliance of exempt chemical preparations with
current statutes or regulations if chemical preparations that have
already obtained exempt status contain newly controlled substances. For
example, although an exempt chemical preparation may continue to be
packaged in the same manner as when it was approved, non-controlled
substances in the preparation may become controlled, thus prompting the
need for a new application for exemption of the chemical preparation to
ensure continued compliance. Other preparations that previously
contained no controlled substances may contain newly controlled
substances and thus would require an application for exemption.
DEA reviews applications for chemical preparation exemptions based
on the statutes and regulations that are in place at the time of the
application, including the control status of substances included in the
preparation. DEA must remain vigilant to ensure that exempt chemical
preparations remain consistent with the standards set forth in the CSA
and its implementing regulations. As such, DEA reminds the public that
any chemical preparation, regardless of whether it was previously
[[Page 4458]]
exempt, that contains a newly controlled substance will require a new
application for exemption pursuant to 21 U.S.C. 811(g)(3)(B) and 21 CFR
1308.23-1308.24.
Review of Exemptions Pursuant to 21 U.S.C. 811(g)(3)
Based on inquiries received from industry, DEA is conducting a
comprehensive review of the exempt chemical preparation regulations.
DEA's regulations at 21 CFR 1308.24(a) state that approved chemical
preparations are exempt from certain provisions of both Subchapter I
and Subchapter II of the CSA: ``The chemical preparations and mixtures
approved pursuant to 1308.23 are exempt from application of sections
302, 303, 305, 306, 307, 308, 309, 1002, 1003 and 1004 of the Act (21
U.S.C. 822-823, 825-829, 952-954) and 1301.74 of this chapter, to the
extent described in paragraphs (b) to (h) of this section.'' Pursuant
to its regulations, DEA has provided exemptions from the application of
section 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 of the
Act (21 U.S.C. 822-823, 825-829, 952-954) and 21 CFR 1301.74 since the
implementation of the regulations in the early 1970s. Until DEA's
analysis of the exemption regulations is complete, DEA will continue to
review and provide exemptions to chemical preparations consistent with
the implementing regulations, when warranted. DEA will publish a future
notice regarding the outcome of DEA's review of its regulations with
respect to the exemption of chemical preparations.
Request for Comment
Pursuant to 21 CFR 1308.23, any interested person may submit
written comments on or objections to any chemical preparation in this
order that has been approved or denied as exempt. If any comments or
objections raise significant issues regarding any finding of fact or
conclusion of law upon which this order is based, the Deputy Assistant
Administrator will immediately suspend the effectiveness of any
applicable part of this order until he may reconsider the application
in light of the comments and objections filed.
Approved Exempt Chemical Preparations Are Posted on DEA's Web site
A list of all current exemptions, including those listed in this
order, is available on DEA's Web site at https://www.deadiversion.usdoj.gov/schedules/exempt/exempt_chemlist.pdf. The
dates of applications of all current exemptions are posted for easy
reference.
Dated: January 14, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2013-01133 Filed 1-18-13; 8:45 am]
BILLING CODE 4410-09-P